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SUMMARY 
Small bowel transplantation (SBTX) is a potentially life-saving solution for patients 
suffering from intestinal failure. Novel immunosuppressive strategies have greatly 
improved the clinical outcome of SBTX, but the survival of grafts is still poor due to non-
immunological reactions caused by hypoxic damage or ischemia/reperfusion (IR) injury. 
Both warm ischemia and cold ischemic periods (i.e. SBTX) are characterized by severe 
biochemical and microcirculatory consequences which affect the integrity of the highly 
vulnerable mucosal barrier. These alterations may range from increased bowel permeability 
to translocation of gut-derived endotoxin and intraluminal bacteria, causing sepsis, multiple 
organ failure or death. The long-term consequences of SBTX also include intestinal 
motility changes caused by denervation during the surgical procedure. 
Ischemic preconditioning (IPC) involves transient, brief periods of ischemia, followed by 
short intervals of reperfusion prior to the final ischemic challenge. Some of the detrimental 
consequences of non-immune-mediated bowel injury can be ameliorated by IPC, but the 
details of the underlying, protective mechanisms are still largely unknown. 
Since microcirculatory reactions can affect the blood supply as well as microvascular 
inflammatory reactions and can critically influence the integrity of the mucosal barrier 
during IR injury, major emphasis was put on the effect of IPC on these changes in relation 
to SBTX in the present studies. Firstly, the consequences of local intestinal IPC were 
examined in a detailed fashion in a large animal model, where bowel innervation is more 
similar to that in humans than in smaller species. In this system, we demonstrated that IPC 
improves macrohemodynamics and intestinal microcirculation and reduces leukocyte-
mediated tissue injury during reperfusion. Nitric oxide (NO) has previously been 
implicated as a mediator in the mechanism of IPC, and neuronal NO synthase (nNOS) is a 
dominant NOS isoform in the gastrointestinal tract. Therefore, the aim of our further studies 
was to investigate the role of nNOS in IPC-induced protection after mesenteric IR using 
the selective enzyme inhibitor 7-nitroindazole. Among the positive effects of IPC, NO 
availability, mucosal pH recovery, amelioration of leukocyte accumulation and mast cell 
degranulation were detected, and morphological injury was reduced by the treatment. 
Therefore, it was concluded that IPC represents an effective tool to ameliorate reperfusion 
injury during SBTX, and the data indirectly proved that NO generated by intestinal nNOS 
plays a pivotal role in IPC-linked tissue protection during IR injury. 
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1. INTRODUCTION 
 
1.1. Clinical indications and complications of small bowel transplantation (SBTX) 
One of the main indications of small bowel transplantation (SBTX) is to overcome the 
negative consequences of short bowel syndrome. Short bowel syndrome is a manifestation 
of “intestinal failure”, which is defined as an inability of the gastrointestinal tract to meet 
the nutritional demands of the body (Kappus M 2016). This often life-threatening condition 
(O’Keefe SJ 2006) is caused by numerous intestinal diseases, including Crohn’s disease, 
mucosal defect, fistulae, vascular complications, radiation enteritis, intestinal obstruction, 
dysmotility, and congenital defect or may evolve secondarily to surgical resection. The 
resultant malnutrition typically necessitates temporary or permanent dependence on 
parenteral nutrition in these patients. Apart from bowel lengthening procedures, improved 
enteric absorptive surface area can be provided via SBTX for patients with severe 
complications of the underlaying intestinal disease or of long-term parenteral nutrition 
therapy (Loo L 2017). 
The first human SBTX was conducted in 1967 (Lillehei RC 1967) several years after 
preclinical and animal studies (Lillehei RC 1959; Starzl TE 1960). Today it is recognized 
that appropriate patient selection should be ensured because of complications related to 
surgery and the necessity of long-term immunosuppressive therapy. Although novel 
immunosuppressive strategies have greatly improved the clinical outcome of SBTX, 
survival of grafts (and thus patients) is still poor and the results markedly worse than the 
success rates for the transplantation of other organs (e.g. kidney, liver or heart) (Legendre 
C 2014; Neuberger J 2016; McCartney SL 2017). This is mainly due to non-immunological 
reactions, such as hypoxic damage or ischemia/reperfusion (IR) injury, which play pivotal 
roles in postoperative graft dysfunction and damage (Mallick IH 2004).  
1.2. Manifestations and mechanisms of ischemia/reperfusion (IR) injury of the bowel  
Within the intestinal mucosal villi, a single-cell epithelial layer of enterocytes forms a 
barrier between the internal milieu and the external environment; therefore, injury to this 
rather vulnerable compartment manifests in changes in bowel permeability, leading to 
detrimental consequences, such as translocation of gut-derived endotoxin and intraluminal 
bacteria (Gayle J 2002; Szabó A 2006), sepsis and eventually multiple organ failure. 
Mucosal barrier dysfunction often occurs due to the consequence of hypoxia caused by 
vascular occlusion (arterial or venous thrombosis and embolism) or hypoxia/reoxygenation 
injury, which also evolves during bowel surgery. Temporary ischemia per se induces the 
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oxygen and energy deficit in the affected tissues (particularly in the villus typs), which is 
followed by reperfusion-induced tissue damage, frequently exceeding the conseqences of 
the ischemic insult itself (Stallion A 2002; Mallick IH 2004). 
Although restoration of the blood supply is essential for tissue survival, the reperfusion 
phase is characterized by an immediate and harmful production of reactive oxygen species 
(ROS). This originates from sequential, univalent reductions of molecular oxygen, leading 
to the formation of superoxide radicals which are subsequently converted to hydrogen 
peroxide and hydroxyl radicals (Parks DA 1982; Parks DA 1983; Granger DN 1986). 
Hydroxyl radicals then cause lipid peroxidation of cell membranes, which brings about 
increased production and systemic release of proinflammatory eicosanoids. The enzyme 
initiating this reaction is xanthine oxidoreductase (XOR), particularly abundant in the gut 
(Parks DA 1988). The XOR-derived superoxide anion can also react with nitric oxide (NO) 
to form peroxynitrite, which is also a reactive promoter of lipid peroxidation and cellular 
membrane damage (Beckman JS 1996). Since ROS also cause endothelial activation, some 
of the subcellular biochemical changes are closely related to deterioration in 
microcirculation in different organs, including the bowel (McCord JM 1985; Schoenberg 
MH 1993; Menger MD 2000; Dejana E 2009; Vollmar B 2011; Park-Windhol C 2016). 
Consequently, impaired endothelium-dependent vasodilation and increased microvascular 
permeability are among the most important consequences of ROS and peroxynitrite 
formation in the gut (Björk J 1982; Parks DA 1983; Beckman JS 1996). As shown by 
intravital videomicroscopy (IVM), incomplete restoration of local microcirculatory blood 
flow (partially due to endothelial injury in the intestinal villi) can also be observed as a 
consequence of IR injury (Guan Y 2009). Furthermore, tissue damage leads to an enhanced 
release of proinflammatory cytokines (e.g. interleukins, platelet activating factor and tumor 
necrosis factor alpha (TNF-α)) (Granger DN 1988; Khan BV 1996; Pober JS 2007). These 
cytokines cause an increased expression of adhesion molecules responsible for the 
interactions between endothelial cells and polymorphonuclear leukocytes (PMNs) 
(Pohlman TH 1986; Sugama Y 1992; Panés J 1999; Pober JS 2007). Nicotinamide adenine 
dinucleotide phosphate-oxidase located in the plasma and phagosomal membranes of 
PMNs, is also an important source of ROS formation, leading to further propagation of 
tissue and microvascular injury (Rybicka JM 2010). 
Importantly, a correlation between the number of recruited PMNs and a high extent of 
tissue damage was also demonstrated (Harris AG 1996). The adhesion of PMNs directly 
induces ROS formation in the postcapillary venules (Granger DN 1986; Suzuki M 1989, 
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1991; Marui N 1993; Khan BV 1996; Lee S 2007), together with platelet−leukocyte 
adhesion (Cooper D 2004; Beuk RJ 2008) and platelet aggregation (Iuliano L 1994; Leo R 
1997; Iba T 2006). These changes further lead to the transmigration of recruited PMNs 
from the endothelial surface of the lumen to the surrounding tissues across the postcapillary 
venules (Grisham MB 1998; Ley K 2007; Woodfin A 2011; Muller WA 2011; Cerutti C 
2017; Schimmel L 2017). ROS promote further activation of PMNs, which enhances 
inflammatory reactions in the microcirculation (Grisham MB 1986; Wankowicz Z 1988; 
Cook-Mills JM 2011).  
1.3. Characteristics of reperfusion injury during SBTX 
Among the biochemical consequences of SBTX, oxidative reactions were demonstrated 
after cold IR, similar to those seen with warm IR in a canine model, and these were reduced 
by conventional preservation solutions (Ferencz A 2002). Reperfusion after SBTX was also 
associated with a progressive decrease in mesenteric blood flow, an increase in mesenteric 
vascular resistance as well as enhanced accumulation and ROS production of PMNs 
(Wolfárd A 1999). It has also been proposed that these leukocyte-mediated postischemic 
microvascular reactions also play an important role in reperfusion injury after cold ischemia 
in small bowel grafts (Gonzalez AP 1994). To study these in vivo reactions, intravital 
fluorescence microscopy can be applied to assess this leukocyte–endothelial cell interaction 
that causes microvascular reperfusion injury in SBTX in rats (Gonzalez AP 1994) and in 
dogs (Wolfárd A 2002), whereas orthogonal polarization spectral (OPS) imaging technique 
can also be used to visualize changes in mucosal morphology and epithelial thickness 
(Wolfárd A 2002). Furthermore, a motoric dysfunction in the graft was observed in rats 
with the involvement of muscularis macrophages during the course of the inflammatory 
processes (Schaefer N 2007).  
Although rodents are easily accessible and frequently used animals in such studies (because 
of a relatively wider range of tests available to detect various inflammatory markers), these 
models also have many obstacles. The gastrointestinal tract of larger animals (e.g. pigs and 
dogs) and especially the innervation of the circular muscle layer of these species have more 
similarities to those of humans than of smaller species (Furness JB 2014). For this reason, 
many earlier studies involved the use of dogs, particularly if examimation of the long-term 
consequences of SBTX were concerned. As such, functional intestinal changes (e.g. 
dysmotility and differently affecting distinct small intestinal regions) were demonstrated in 
dog models 2 and 8 weeks after denervation (Zyromski NJ 2002), which was followed by 
a jejunal cholinergic and adrenergic smooth muscle hypersensitivity phase 2 weeks after 
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surgery (Balsiger BM 2003). Furthermore, altered intestinal transit time (delayed 
gastroduodenal emptying), reduced intestinal flow rates (Johnson CP 2001) and impaired 
absorption were attributed to the presence of intestinal denervation in dogs after 4–12 
weeks (Ishii H 1993; Tsiotos GG 2001). Diarrhea caused by malabsorption of water and 
electrolytes as well of the effect of altered bile salt secretion were also observed as a result 
of denervation 8 weeks after SBTX in dogs (Oishi AJ 1995). Plasma levels and composition 
of gastrointestinal hormones were similarly shown to be moderately altered after SBTX in 
similar canine models after 2–12 weeks (Nelson DK 1993; Adrian TE 1994).  
1.4. Nitric oxide (NO) production in the gut  
Being a highly effective vasodilator molecule, NO is an important intrinsic regulator of 
vascular tone under both healthy and diseased conditions. As for the gut, the mucosal blood 
flow, oxygen uptake and intestinal motility (Brookes SJ 1993) are simultaneously 
determined by NO-dependent mechansims (Alemayehu A 1994; Salzman AL 1995; Qu 
XW 2005; Nair J 2019). At a microcirculatory level, NO has important anti-adhesive 
characteristics (Gaboury J 1993). The inhibition of constitutive forms of NO synthesis 
evokes the recruitment of adherent PMNs and causes intestinal mucosal damage (Kubes P 
1991, 1993b, 2000). During IR challenge, NO donors and NO-releasing compounds (e.g. 
SIN-1, sodium nitroprusside, CAS 754 and FK409) markedly attenuate IR-induced tissue 
injury and preserve mucosal barrier function in many species (Qu XW 1999a, 1999b; Emre 
A 2008), including cats (Kanwar S 1994b) and dogs (Kawata K 2001; Payne D 1993). 
Similarly, blockade NO synthesis exacerbates the consequences of small bowel IR (e.g. 
mucosal barrier dysfunction), and this effect was reversed by L-arginine administration 
(Kubes P 1993a). On the other hand, the contribution of NO-derived peroxynitrite to tissue 
injury in the postischemic intestine was also demonstrated (Cuzzocrea S 1998).  
In the gastrointestinal tract, three endogenous isoforms of nitric oxide (NO) synthase 
(NOS), neuronal NOS (nNOS), endothelial NOS (eNOS) and inducible NOS (iNOS) are 
responsible for NO production (Qu XW 1999b). In all three cases, the biosynthesis 
pathways use L-arginine, molecular oxygen and, additionally, nicotinamide adenine 
dinucleotide phosphate (NADPH) and tetrahydrobiopterin (BH4), leading to the production 
of NO and L-citrulline (Knowles RG 1994). These isoforms have different calcium 
dependence: eNOS and nNOS are Ca2+-dependent, while iNOS is Ca2+-independent 
(Alderton WK 2001). Among the two Ca2+-dependent constitutive isoforms, neuronal NOS 
(nNOS or type I NOS) is a predominant isoenzyme in the rat small intestine (Qu XW 1999a, 
1999b). Similar isoenzyme distribution was demonstrated in later experimental studies in 
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the small intestine in large animals as well. As such, a marked pharmacological inhibition 
of the constitutive enzyme activity with 7-nitroindazole (7-NI) (Moore PK 1996) (by 40–
70% from the oral to the aboral direction, respectively) was achieved in the colon in a 
canine model of bowel obstruction, suggesting a relatively high activity of nNOS in the 
gastrointestinal tract (Palásthy Z 2006).  
Interestingly, stable end-products of NO (nitrite and nitrate) were primarily found on the 
apical side of intestinal epithelial cells (Witthöft T 1998). NO has also been shown to 
influence tight junction protein expression of intestinal epithelial cells and to regulate their 
function via free radical-dependent mechanisms (Mu K 2019). This latter effect may be 
based on numerous mechanisms, including the scavenging effect of lipid or protein 
radicals, and on hydrogen peroxide-induced changes in the protein tyrosine 
phosphorylation of enterocytes (Katsube T 2007), by altering the glutathione 
(GSH/GSSG)-related effects on phosphatases and protein tyrosine phosphorylation, and 
finally via redox change-induced effects on enzymes (Schafer FQ 2001; Gow AJ 2004; 
Tegeder I 2019). 
It appears that bowel IR is associated with damage to NOS-positive neurons (swelling and 
distortion) (Rivera LR 2009, 2011b) in small animal models and, in parallel, with changes 
in gastrointestinal motility (notably a slowing of transit) (Udassin R 1995; Grossie VB Jr 
2001; Türler A 2002; Hakgüder G 2002). These changes (complete damage to these 
neurons) can be detected after 2 days. Apart from structural injury, nitrosylation of proteins 
via a peroxynitrite-dependent mechanism may also represent a manifestation of IR injury 
(Ferrer-Sueta G 2009). These peroxynitrite-related events via nitrosylate tyrosine of 
proteins may also contribute to the function of proteins (including NOS). Further, NO may 
play a role in cytotoxic damage to neurons as a result of increased cytoplasmic Ca2+, which 
triggers excess NO production by the Ca2+-dependent NOS isoforms (Dong Z 2006). 
Although S-nitrosylation is a physiological mechanism of the signal transduction of NO, 
excess production of nitrosylate tyrosine residues or cysteine nitrosothiols can contribute 
to protein misfolding and eventually to neuronal damage (Stamler JS 1992; Nakamura T 
2007; Foster MW 2009; Savidge TC 2011; Rivera LR 2011a, 2011b).  
It appears that intestinal IR injury evokes an acute inflammatory response, and the role of 
nNOS in this scenario remains controversial. Several groups have attributed a pro-
inflammatory role to nNOS (Altay T 2004; Qu XW 2005; Iijima H 2005; Enkhbaatar P 
2009), but anti-inflammatory properties have also been described by others (Beck PL 
2004). In rats, nNOS supresses iNOS expression (via a nuclear factor-kappa B (NF-
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κB)/IκBα dependent mechanisms; Qu XW 2001), while inhibition of nNOS (with 7-NI) for 
four days) caused tissue invasion of PMNs (as assessed by intestinal myeloperoxidase 
enzyme activity; MPO) (Qu XW 2001). The paradoxical role of nNOS-mediated NO 
signaling during inflammation may result from the differences in disease severity (colitis, 
sepsis, cerebrovascular inflammation, etc), sample timing, and, of course, in the animal 
model used, i.e. rodents versus large animals). 
Another possible source of NO is enzyme-independent and could be derived from tissue 
accumulation of nitrite during the ischemic phase (Zweier JL 1995). There are multiple 
pathways of NO formation from nitrite in biological systems under ischemic conditions. 
Nitrite is reduced to NO at the molybdenum site of the xanthine oxidase enzyme with 
xanthine, NADH and 2,3-dihydroxybenz-aldehyde substrates (Li H 2001). NO is also 
generated from nitrite reduction by the cytosolic molybdenum enzymes aldehyde oxidase. 
These NOS-independent NO productions from nitrite are produced primarily in tissues not 
in the blood and regulated by pH, oxygen tension, and nitrite, as well as by reducing 
substrate concentrations in the rat liver and heart (Li H 2008). 
1.5. Ischemic preconditioning (IPC) in the intestine and the role of NO 
Ischemic preconditioning (IPC) with brief periods of intermittent ischemia is known to be 
a potent intervention to reduce the consequences of IR. Its aim is to increase the ischemic 
tolerance of tissues. This approach was first described in the heart (Murry CE 1986), but it 
was later demonstrated in many organs, including the intestine (Hotter G 1996; Tamion F 
2002). This multifactorial defensive cellular phenomenon involves many targets and 
mechanisms (including malondialdehyde (MDA), TNF-α, intercellular adhesion molecule-
1 (ICAM-1) and vascular adhesion molecule-1 (VCAM-1)) in the intestine, including 
moderation of the severity of oxidative stress and activation of endogenous cellular 
adaptation processes in bowel tissue (Sola A 2000; Ferencz A 2002; Ji YY 2015). The 
attenuating effect of IPC against early stages of inflammatory response (Camprodon RA 
2014) includes down-regulation of the expression of transcription factor NF-κB (Ferencz 
A 2002; Wei Z 2009) with resultant cytoprotection via the inhibition of apoptotic cascade 
(Maulik N 1999). IPC-induced improvement of IR injury also manifests in protection of 
the villous microcirculation in rodents (Mallick IH 2005b) and in prevention of intestinal 
motility dysfunction via preservation of jejunal enteric nerve function in rats (Taha MO 
2012). In other studies (performed on rats), IPC exerted marked protection of intestinal 
mucosa (in particular villus tips), which manifest in reduced mucosal permeability 
(McCallion K 2000; Maretta M 2012,) and apoptosis (Sileri P 2004) in the early reperfusion 
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phase (<120 min) and in enhanced IPC-induced mucosal regeneration in the later phase 
(Maretta M 2012). 
Similarly to IR, the protective role of IPC was also demonstrated with SBTX. The 
protective effect of IPC is associated with altered gene expression (cell adhesion, energetic 
and substrate metabolism, and early response gene activation) in SBTX at early stages of 
reperfusion in rats (Wang S 2009), IPC-ameliorated oxidative stress (MDA, superoxide 
dismutase (SOD), GSH and XOR) (Sola A 2000; Ferencz A 2004) and inhibited NF-κB 
expression after SBTX in dogs (Ferencz A 2002), and reduced apoptotis in rats (Wang SF 
2003). Furthermore, IPC has been shown to ameliorate IR-induced endothelial activation 
as evidenced by reduced early shedding of adhesion molecule ICAM-1 from the endothelial 
surface during SBTX (Camprodon RA 2014). During heterotopic SBTX in rats, the IPC-
evoked release of hem-oxigenase-1 is thought to play a role in reducing systemic 
consequences (lactate-dehydrogenase (LDH), aspartate-aminotransferase and alanine-
aminotransferase) of SBTX (3 h reperfusion; Saeki I 2011). 
Some of the protective effects of IPC (e.g. LDH and morphology) were also attributed to 
NO-dependent mechanisms in the intestine (Hotter G 1996; Sola A 2001). A transient NO 
release at the onset of reperfusion could be directly detected by NO-sensitive 
microelectrodes in different organs (testis: Kono T 2006; heart: Takahashi SS 2003; liver: 
Lhuillier F 2003; kidney: Saito M 2000; urinary bladder: Saito M 1999; stomach: Wada K 
1998; brain: Ohta K 1996) and in the bowel (Watanabe T 2007). Interestingly, remote IPC 
resulted in an enhanced NO release during both the ischemic and reperfusion phases in the 
heart (Kang SW 2013). With SBTX, NO donors mitigated reperfusion injury after 
IPC+SBTX (Sola A 2001) and reduced tissue of MDA and MPO levels at early reperfusion 
(Cao B 2005), whereas NOS inhibition with N(ω)-nitro-L-arginine methyl ester (L-NAME) 
prevented the IPC-induced protection (as concerns LDH and MPO changes) (de Oca 1999) 
in rats. Therefore the involvement of Ca2 +-dependent NOS (cNOS)-derived NO in IPC-
induced protection seems to be confirmed, but the potential role of nNOS is examined to a 
lesser extent. Although IPC did not decrease the size of the infarct area in eNOS or nNOS 
knockout mice (Atochin DN 2003), nNOS was found to be protective for heart IPC both in 
vitro (against necrosis, apoptosis and CK release) and in vivo (via mitoKATP and 
p38MAPK-dependent pathways, Barua A 2010; oxidative/nitrosative stress, Lu XM 2009) 
as the positive effect of IPC is lost after nonspecific NOS inhibition and in nNOS knock 
out animals (Lu XM 2009). Furthermore, the post-translational modification and 
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modulatory effect of IPC on nNOS activity were also demonstrated in a cerebral ischemia 
model (Wang M 2016).  
1.6. Mast cell (MC)-driven cellular reactions during intestinal IR and SBTX – possible 
interplay between NO, PMNs and MCs 
The mechanisms of IR injury involve not only direct tissue injury (elicited by the IR insult), 
but also secondary (usually also delayed) damage caused by inflammatory activation 
(Sheridan AM 2000). Activation of mast cells (MCs) is one of the manifestations of IR-
related inflammatory reactions (Boros M 1995; Andoh A 2001). MCs are located close to 
the arterioles and venules of the gastrointestinal mucosa (Kunder CA 2011), and a contact 
similar to a synapsis also exists between nerves and MCs (Stead RH 1989; Blennerhassett 
MG 1991). MC activation/degranulation can be brought about by both extracellular and 
intracellular pathways. Extracellular pathways are mediated by a series of G protein-
coupled receptors (Kuehn HS 2007), e.g. endothelin-A receptors (Szalay L 2000), 
adenosine receptors 2A and 3 (Fozard JR 1996) and anaphylatoxin receptors C3a or C5a 
(Fukuoka Y 1990) on the MC surface. The intracellular pathways include MC 
degranulation without extrinsic signals or involvement of cell surface receptors, and these 
pathways are linked to ROS formation (Suzuki Y 2005). These signals typically induce 
phospholipase C activation and calcium mobilization, leading to MC degranulation 
(Fukuoka Y 1990; Murray DB 2004; Kuehn HS 2007) with a resultant release of chemicals, 
including histamine (Boros 1991) and chymase (Galli SJ 2005). ROS generated during the 
reoxygenation phase can alone trigger intracellular signal transduction pathways of MCs 
(Lefer DJ 2000; Matsui T 2000) and resultant MC degranulation (Becker BF 2000). Apart 
from preformed molecules, de novo synthesis of mediators with high pro-inflammatory 
potential are also produced by MCs, e.g. TNF- (Bischoff SC 2009), platelet activating 
factor (Kurose I 1997), leukotriene B4 (Su M 1993), prostaglandin D2 (Wingard CJ 2011) 
and chemoattractants, including CXCL1/CXCL2 (Katsanos GS 2008; De Filippo K 2013) 
and CC chemokines (Wan MX 2003). Some of the reactions are also modulated by nerve 
plexus-MC interactions in the gut (Tikoo S 2018). The above chemoattractants bring about 
PMN accumulation in target damaged tissue (Kanwar S 1994d; Strbian D 2006; De Filippo 
K 2013), and pro-inflammatory cytokines released during MC degranulation induce 
expression of adhesion molecules (selectins and integrins) (Zhang J 2011), which further 
lead to PMN transmigration (Ley K 2007; Woodfin A 2011; Muller WA 2011; Cerutti C 
2017; Schimmel L 2017). A correlation between MC-induced increase in MPO activity and 
the extent of small intestinal IR injury has also been demonstrated (Andoh A 1999; Gan X 
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2013). Of note, contribution of MCS to the IR-induced increase in microvascular (Kubes P 
1996) and mucosal permeability (Kanwar S 1994a; Szabó A 1997) has been demonstrated 
as well. 
It appears that NO is able to inhibit MC-induced PMN rolling and adhesion in the 
mesenteric venules (Gaboury JP 1996; Niu XF 1996) and endogeneously produced NO 
attenuates intestinal IR injury by ameliorating MC degranulation in rats (Hutcheson IR 
1990). Activation of mucosal or serosal MCs leads to the production of NO (Hirji NS 1999) 
through induction of iNOS in rodents (Bidri M 1997). Interestingly, an interaction between 
nerves and MCs has also been demonstrated: (1) expression of complementary receptors 
on MC and neighboring nerves were demonstrated, which may bring about receptor-
mediated activation of intracellular signaling pathways (Schemann M 2013); (2) 
neurotransmitters and mediators released by neurons influence MC degranulation (Galli SJ 
2008); (3) impulses generated by neurons during inflammation result in release of 
adenosine triphosphate, vasoactive intestinal peptide, substance P and calcitonin gene-
related peptide, and these substances are known to trigger MC activation (Buhner S 2012). 
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2. MAIN GOALS OF THE STUDIES 
 
The main goal of the studies was to determine the consequences of local intestinal IPC in 
a detailed fashion in a large animal model. Since microcirculatory reactions can affect the 
blood supply as well as microvascular inflammatory reactions and can critically influence 
the integrity of the mucosal barrier during IR injury, major emphasis was put on the effect 
of IPC on these changes in relation to SBTX. Thus, we directly observed the intestinal 
microcirculations by intravital microscopy (using conventional fluorescence IVM and OPS 
imaging methods) in order to assess the responses to a local IR challenge elicited by cold 
ischemia.  
Since NO has been implicated as a trigger/mediator in the IPC mechanism and since nNOS 
is a dominant isoform of NOS in the gastrointestinal tract, an additional aim of our studies 
was to examine the possible role of nNOS in the local IPC-induced protection in the 
intestine with particular interest in intestinal motility function and inflammatory reactions.  
 In this context, our first objective was to compare the effects of IPC on the 
consequences of cold and warm IR during the early reperfusion phase in anesthetized 
dogs with respect to (1) local intestinal microcirculatory inflammatory and 
microvascular perfusion reactions, (2) potential denervation-related events, (3) 
involvement of MCs, and (4) morphological injury.  
 Secondly, we set out to examine the possible involvement of nNOS in local IPC-
induced protection in a surgically induced intestinal IR model in anesthetized dogs. To 
this end, 7-NI, a specific inhibitor nNOS was administered prior to IPC. Changes in 
(1) macro- and microhemodynamics, as well as in (2) leukocyte accumulation, (3) MC 
activation, (4) intestinal motility, (5) local NO production, and (6) structural injury 
were assessed. 
17 
 
3. MATERIALS AND METHODS 
 
The experiments were performed in 2 major studies on large animals. In both studies, the 
macro- and microcirculatory as well as biochemical effects of bowel IPC were examined. 
In Study 1, the above effects of IPC were examined in a small bowel autotransplantation 
model in dogs. In the second study, the role of nNOS in the IPC-induced protection was 
assessed in a canine model of small bowel IR.  
3.1. Animals 
The experiments complied with the ARRIVE guidelines and the project was approved by the 
National Scientific Ethics Committee on Animal Experimentation (National Competent 
Authority) in Hungary under license numbers VI./15.1/00755/001/2005 and V./148/2013. The 
study was performed in compliance with Directive 609/86/EEC and Directive 2010/63/EU on 
the protection of animals used for experimental and other scientific purposes and the National 
Institutes of Health guidelines on the use of experimental animals (NIH Publications No. 8023, 
revised 1978). 
3.2. Surgical preparation 
In both studies, outbred dogs of either sex (body weight range: 12.2–17.3 kg) were obtained 
from the Animal House of the University of Szeged. The animals were deprived of food, 
but not water, for 24 h prior to the experiments. The animals were anesthetized 
intravenously with sodium pentobarbital (30 mg/kg iv). Endotracheal intubation was 
applied to facilitate respiration, and body temperature was maintained at 37°C with a 
homeothermic blanket. In aseptic techniques, polyethylene catheters were surgically 
inserted into the femoral artery and vein to measure blood pressure and administer fluids 
or drugs, respectively. All the animals received a continuous infusion of Ringer’s lactate at 
a rate of 10 ml/kg/h during the experiments.  
3.3. Experimental protocols 
Study 1 
In this study, 8 male and 7 female outbred dogs were randomly allocated to sham-operated 
(n=5; male=3, female=2) and SBTX (n=10; male=5, female=5) groups. After anesthesia 
and vessel cannulations (see above), a Swan-Ganz thermodilution catheter (Corodyn TD-
EN, 5011-110-7Fr; Braun Melsungen AG, Melsungen, Germany) was placed into the 
pulmonary artery via the left femoral vein to measure cardiac output by thermodilution. 
Following median laparotomy, the root of the superior mesenteric artery (SMA) was 
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dissected free, and an ultrasonic flow probe (Transonic Systems Inc., Ithaca, NY, USA) 
was placed around the exposed SMA to measure mesenteric blood flow. A branch of a 
tributary of the ileal vein supplying the terminal part of the ileum was cannulated with a 2-
F polyethylene catheter to measure mesenteric venous pressure and to obtain blood samples 
(see later).  
In animals where orthotopic SBTX was performed, the spleen was first removed after an 
upper transverse laparotomy and the root of the SMA and vein was dissected free. The 
mesentery of the small bowel was divided between ligations in the distal (ileocolic) and 
proximal (duodenojejunal) parts, and the intestinal wall was transected. The SMA was then 
cannulated with a 7-F polyethylene catheter, and the small intestine was removed from the 
abdominal cavity. The intestinal graft was perfused with 500 ml chilled (4°C) heparinized 
Ringer’s lactate at a perfusion pressure of 100 cm water. The graft was stored on ice until 
the vessels were reanastomosed end-to-end with 6/0 running sutures (nonabsorbable 
polypropylene). After 60-min cold ischemia, reperfusion was induced and the macro- and 
microhemodynamic changes were observed hourly for 4 h after revascularization. The 
SBTX group (n=5) went through the above procedures only, and, in the following group, 
the experimental protocol was identical to that described above, except that an IPC was 
also performed (3 times 5-min SMA occlusion, followed by 10 min of reperfusion) 60 min 
prior to ischemia induction (IPC+SBTX group, n=5). The last group served as a sham-
operated control, without bowel harvesting (sham-operated group, n=5). In these animals, 
a laparotomy and splenectomy were performed and the mesenteric vessels were cannulated 
for hemodynamic measurements. All manipulations were identical to those in the other, 
treated groups, with the exception that the bowel was not perfused and harvested. There 
was no significant difference between the 3 groups as concerns the duration of the surgical 
preparation or the cold ischemia time in SBTX and IPC+SBTX groups. In this study, 
macro- and microhemodynamic measurements were performed every 60 min (see later) 
(Figure 1).  
After a stabilization period, the basal cardiovascular parameters were measured for 20 min. 
Control intravital microscopic measurements (functional capillary density (FCD), 
epithelial thickness and red blood cell velocity (RBCV); see later) were performed before 
perfusion (Figure 1). For technical reasons (the experimental animal needs to be transported 
beyond the microscope), certain baseline microcirculatory measurements (to assess PMN-
endothelial interactions; see later) were not taken before perfusion. After these 
measurements in the IPC+SBTX group, complete SMA occlusion was performed 3 times 
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for 5 min, followed by 10 min of reperfusion. Sixty minutes after IPC, perfusion of the 
graft was performed. Then, after 60 min cold ischemia vascular anastomoses were 
conducted, and reperfusion was monitored for 4h. Leukocyte-endothelial cell interactions 
were monitored hourly by IVM during the 4-hour reperfusion phase. Tissue biopsies were 
also harvested from the intestine for further histological (MC degranulation) analyses (at 
baseline and 240th min of reperfusion) (Table 1). 
 
 
Figure 1. Experimental protocol of Study 1. Orthotopic small bowel transplantation (SBTX) was 
performed, and the intestinal graft underwent 60 min cold ischemia, which was followed by 240 
min of reperfusion (SBTX group, n=5). In another group, an identical experimental protocol was 
performed except that cold ischemia was preceeded by 3 cycles of 5-min ischemia/10-min 
reperfusion periods (IPC) 60 min prior to ischemia (IPC+SBTX group, n=5). The last groups served 
as a sham-operated control (n=5). Leukocyte-endothelial cell interactions were monitored hourly 
by intravital videomicroscopy (IVM) during the reperfusion phase. An intravital orthogonal 
polarization spectral (OPS) imaging technique was used to monitor microvascular perfusion 
changes (functional capillary density, epithelial thickness and red blood cell velocity) and 
enterocyte injury in the intestinal villi before harvesting and hourly during the reperfusion phase 
after SBTX. Tissue biopsies from the affected bowel area (marked by an arrowhead) were also 
taken for histological assessments of mast cell degranulation. 
 
Study 2 
In the second study, 10 male and 9 female outbred dogs were randomly allocated to IR 
(n=7; male=4, female=3) and IPC (n=12; male=6, female=6) groups (Figure 2). In the IR 
group, mesenteric ischemia was elicited by occluding the SMA for 60 min with a miniclip, 
which was followed by 2 h of reperfusion. In the IPC group, animals were assigned to 7-
NI-treated or vehicle groups and were treated with the selective nNOS inhibitor 7-NI (5 
mg/kg; n=6; male=3, female=3) or saline vehicle (n=6; male=3, female=3) in an iv bolus 
15 min prior to IPC. IPC was induced in 2 groups by clamping the SMA using 3 cycles of 
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5-min ischemia/5-min reperfusion periods starting 60 min before IR. Stock solution of 7-
NI (Sigma-Aldrich Co., St. Louis, MO, USA) was dissolved in a mixture of 75% 
DMSO/saline and stored at –20°C; the aliquots were diluted in 3 ml of 0.9% saline before 
administration. In the IR group, the animals were treated with the saline vehicle at a 
matching time point. 
Blood samples were collected from the mesenteric vein for later determination of plasma 
nitrate/nitrite (NOx) levels at different time points (see at Figure 2). Tissue biopsies were 
also harvested from the intestine for further biochemical/histological (e.g. MPO, NOS 
activity and MC degranulation) analyses (at baseline as well as at the 15th and 120th min of 
reperfusion) (Table 1).  
 
 
 
Figure 2. Experimental protocol of Study 2. In the first group, 60 min of ischemia was induced by 
occluding the superior mesenteric artery (SMA), which was followed by 120 min of reperfusion 
(IR). In the two other groups, IR was preceded by ischemic preconditioning (IPC), which was 
elicited by inducing 3 cycles of 5-min ischemia/5-min reperfusion periods in the presence and 
absence of a bolus injection of 7-nitroindazole (7-NI, 5 mg/kg) 15 min prior to IPC (IPC+IR+7NI 
and IPC+IR groups, respectively). IR and IPC+IR groups were treated with a vehicle of 7-NI (a 
mixture of 75% DMSO/saline) at corresponding time points. As indicated, blood samples from the 
mesenteric vein (BS) and tissue biopsies from the affected bowel area (marked by an arrowhead) 
were also taken for later assessments of plasma nitrate/nitrite levels and nitric oxide synthase and 
myeloperoxidase activities, as well as to assess mast cell degranulation and mucosal injury. 
  
21 
 
Table 1. A list of interventions and examined parameters in Studies 1 and 2  
 Study 1 Study 2 
Small bowel transplantation  +  
Duration of ischemia  60’ 60’ 
Ischemic preconditioning  3x5’/10’ 3x5’/5’ 
Reperfusion 4 hr 2 hr 
Cardiac output measurements +  
Superior mesenteric artery blood flow measurement + + 
Assessment of PMN-endothelial interactions (IVM) +  
Assessment of RBCV in capillaries of the villi (OPS) +  
Assessment of intramucosal pH   + 
Assessment of ileal motility   + 
Plasma nitrate/nitrite measurement  + 
Nitric oxide synthase activity  measurements in the ileum  + 
Assessment of morphological changes (villus tips; OPS) +  
Assessment of morphological changes (histology: Chiu’s grade, 
villus height) 
 + 
Assessment of mast cell degranulation (histology) + + 
 
3.4. Hemodynamic and blood gas measurements; calculation of intramucosal pH (pHi) 
In both studies, the peripheral arterial and mesenteric venous pressures as well as SMA 
flow (using Statham P23 Db transducers) were registered with a computerized data-
acquisition system (Haemosys 1.17 Experimetria Ltd., Budapest, Hungary). In Study 1, a 
Swan-Ganz thermodilution catheter (Corodyn TD-EN, 5011-110-7Fr; Braun Melsungen 
AG, Melsungen, Germany) was also placed into the pulmonary artery via the left femoral 
vein to measure cardiac output by thermodilution. In Study 2 a silastic balloon catheter 
(TGS Tonomitor, Tonometrics Inc., Worcester, MA, USA) was introduced through a small 
enterotomy into the intestinal lumen. Arterial blood gases and intramucosal pCO2 were 
measured with a blood gas analyzer (AVL, Graz, Austria). Intramucosal pH (pHi) was 
calculated by using the modified Henderson–Hasselbach formula with a correction factor 
for 30 min of equilibration. 
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3.5. Intravital fluorescence videomicroscopic (IVM) examinations of PMN-endothelial 
interactions  
In the first Study, the mesenteric microcirculation was analyzed using an epi-illumination 
technique. An ileal segment with intact neurovascular connections was gently placed on a 
specially designed stage. During the entire in vivo microscopic procedure, the tissue was 
constantly bathed in 37°C Ringer’s lactate to avoid drying and exposure to ambient air. 
Leukocyte-endothelial cell interactions in the postcapillary venules of the mesentery were 
monitored with a high-resolution Zeiss Axiotech Vario 100 HD fluorescent intravital 
microscope (100 W HBO mercury lamp, Acroplan 20 X water immersion objective, Ex: 
495 nm, Em: 515 nm). The microscopic images were recorded by a charge-coupled device 
video camera (AVT HORN-BC 12) attached to an S-VHS video recorder (Panasonic AG-
MD 830) and a personal computer. Leukocytes were stained in vivo by means of 
rhodamine-6G (Mw 479, Sigma, St. Louis, MO, USA; 0.2%, 0.1 ml iv). Quantitative 
assessment of the microcirculatory parameters was performed off-line by frame-to-frame 
analysis of the videotaped images (Pictron Ltd., Budapest, Hungary) within 5 postcapillary 
venules per animal, including the observation of nonadherent, adherent and rolling 
leukocytes. Adherent leukocytes (stickers) were defined in each vessel segment as cells 
that did not move or detach from the endothelial lining within an observation period of 30 
seconds and are given as the number of cells per square millimeter of endothelial surface, 
calculated from the diameter and length of the vessel segment observed, assuming 
cylindrical geometry. Rolling leukocytes were defined as cells moving at a velocity of less 
than 2/5 of that of the erythrocytes in the centerline of the microvessel and are given as a 
percentage of the nonadherent leukocytes passing through the observed vessel segment 
within 30 second. 
3.6. Orthogonal polarization spectral (OPS) imaging technique for assessment of 
microvascular velocity and morphological changes of the intestine 
In the first study, an intravital OPS imaging technique (Cytoscan A/R, Cytometrics, PA, 
USA) was used to monitor microvascular perfusion changes in the intestinal villi before 
harvesting and during the reperfusion phase after transplantation. The OPS imaging 
technique utilizes reflected polarized light at 548 nm, which is the isosbestic point of oxy- 
and deoxyhemoglobin. Since polarization is preserved in reflection, only photons scattered 
from relatively deep inside the tissue contribute to the images. In this way, a virtual light 
source is created in the tissues so that the vessels appear black. The method is 
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suitable for visualizing all hemoglobin-containing structures, without the use of a 
fluorescent dye. A 10x objective was introduced into the intestinal lumen through a small 
enterotomy on the antimesenteric side of the bowel. The objective was connected to a light 
source with flexible cables; thus, this intestinal segment was not exteriorized during the 
study. Quantitative assessment of the microcirculatory parameters was performed off-line 
by frame-to-frame analysis of the videotaped images. The FCD (length of perfused 
nutritive capillaries per observation area (centimeter –1), the RBCV (millimeters/second) 
in the central arterioles and venules of the villi and the thickness of the epithelial cell layer 
covering the intestinal villi (micrometers) were determined in 5 separate fields by means 
of a computer-assisted image analysis system (IVM Pictron®). All data were expressed as 
the means of 5 measurements at each time point. 
3.7. Intestinal motility measurements  
In Study 2, a modified strain gauge transducer technique was applied to monitor the small 
bowel motility, and the motility index was calculated to estimate the neurogenic integrity 
of the intestine (Palásthy Z 2006). Briefly, two strain gauge transducers (FSG-02 type; size: 
6x15 mm; Experimetria Ltd., Budapest, Hungary) were sutured to the circular muscle layer 
of an ileum segment in a parallel position using 5/0 silk suture material (Braun-Dexon, 
Melsungen, Germany). The strain gauge transducer wire was connected to an SG-M bridge 
amplifier, and the signals were continuously recorded with a computerized data-acquisition 
system (Haemosys 1.17; Experimetria Ltd., Budapest, Hungary). Signal analysis was 
performed offline, and the bowel motility index was determined by calculating the area 
under the motility curve as a function of time (Huge A 1998).  
3.8. Plasma nitrate/nitrite (NOx) level measurements 
In Study 2, plasma NOx concentrations were determined from samples taken at baseline (t= 
–30 min), before ischemia as well as at the 15th, 60th and 120th min of reperfusion by means 
of the Griess reaction. Blood samples were centrifuged at 10 000 g for 15 min at 4°C, and 
the plasma samples were stored at –20°C for a maximum of 2 months. The plasma was 
mixed with b-nicotinamide adenine dinucleotide phosphate, flavin adenine dinucleotide 
and nitrate reductase (Sigma-Aldrich Co., St. Louis, MO, USA) and incubated for 30 min 
at 37°C. Following the enzymatic reduction of nitrate to nitrite, the Griess reagent was 
added to the mixture and incubated for an additional 10 min at room temperature. The 
absorbance of the azo compound was measured spectrophotometrically at a wavelength of 
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540 nm, and the total NOx concentration (mmol/l) was determined using a standard 
calibration curve of NaNO2 and NaNO3 (Sigma-Aldrich Co., St. Louis, MO, USA). 
3.9. Measurement of nitric oxide synthase (NOS) enzyme activity  
In Study 2, a specific method to determine NOS activity based on the enzymatic conversion 
of 3[H]-L-arginine to 3[H]-L-citrulline was described earlier (Palásthy Z 2006). Briefly, 
intestinal tissue biopsies were homogenized on ice in a phosphate buffer (pH 7.4; 50 mM 
Tris-HCl, 0.1 mM EDTA, 0.5 mM dithiotreitol, 1 mM phenylmethylsulfonyl fluoride and 
10 µg/ml soybean trypsin inhibitor, 10µg/ml leupeptin), and then the homogenate was 
centrifuged at 24000 g for 20 min at 4°C. The supernatant was transferred to centrifugal 
concentrator tubes (Amicon Centricon-100; 100000 MW cut-off ultrafilter, Merck KGaA, 
Darmstadt, Germany), and samples were centrifuged at 900 g for 150 min at 4°C. After the 
second centrifugation, the concentrated supernatant was washed out of the ultrafilter with 
250 µl homogenizing buffer. Samples were incubated for 5 min with a cation-exchange 
resin (Dowex AG 50W-X8, Na+ form, Dow Chemical Company, Midland, MI, USA) to 
deplete endogenously produced L-arginine. The resin was removed by centrifugation at 
1500 g for 10 min and a supernatant-containing enzyme was used for a NOS activity assay. 
cNOS activity was assessed in the presence of a 50 µl enzyme extract and a 100 µl reaction 
mixture (pH 7.4, containing 50 mM Tris-HCl buffer, 1 mM NADPH, 10 µM 
tetrahydrobiopterin, 1.5 mM CaCl2, 100 U/ml calmodulin and 0.5 µCi [3H] L-arginine 
(Amersham BioSciences UK Ltd,, Amersham, UK) specific activity 63 Ci/mmol) after 60 
min of incubation at 37°C. The enzyme reaction was terminated by adding 2 mM EGTA 
and 2 mM EDTA containing an ice-cold HEPES buffer (pH 5.5, in 1 ml volume of buffer). 
NOS-independent 3[H]-L-citrulline formation was assessed in the presence of a non-
selective NOS inhibitor, N-ω-nitro-L-arginine (3.2 mM, Sigma Chemical Co., St. Louis, 
MO, USA). Ca-calmodulin was omitted in determining Ca2 +-independent NOS activity 
(iNOS), while EGTA (8 mM) was added to the reaction mixture. A 1-ml reaction mixture 
was applied to the Dowex cation-exchange resin (AG 50W-X8, Na+ form) and eluted with 
2 ml dH2O. The eluted [
3H] L-citrulline activity was determined with a scintillation counter 
(Tri-Carb Liquid Scintillation Analyzer 2100TR/2300TR; Packard Instrument Co., 
Meriden, CT, USA). Total protein concentrations in samples were determined using the 
Lowry method. 
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3.10. Tissue myeloperoxidase enzyme activity (MPO) measurements 
In Study 2, MPO, a marker of neutrophil granulocyte infiltration, was measured from 
mucosal biopsies (Kuebler WM 1996). Briefly, the tissue was homogenized with Tris-HCl 
buffer (0.1 M, pH 7.4) containing 0.1 mM polymethylsulfonyl fluoride to block tissue 
proteases and then centrifuged at 4°C for 20 min at 5000 g. The MPO activities of the 
samples were measured at a 450 nm wavelength (UV-1601 spectrophotometer, Shimadzu, 
Japan), and values were normalized to protein content. 
3.11. Determination of MC degranulation 
In both studies, ileal biopsies were placed into an ice-cold Carnoy’s fixative, embedded in 
paraffin, sectioned (6 m) and stained with Alcian blue and Safranin O. Histological 
analysis was performed in coded sections by one investigator at 40x optical magnification 
in a blinded fashion. MCs were differentiated based on the location of granules, injury to 
the cell membrane and volume of the cytoplasm. Intact cells were characterized by (1) 
intact membrane and (2) cytoplasmic granules, while criteria for degranulated cells were 
specified by (1) cell membrane injury, (2) reduced cytoplasmic volume, and (3) loss of 
cytoplasmic granules. The percentage of degranulation (MC%) was calculated based on the 
number of intact (iMC) and degranulated (dMC) mast cells: MC% = dMC / (dMC+iMC) 
(Gera L 2007). 
3.12. Determination of morphological changes in the structure of the small intestine 
In the first Study, the thickness of the epithelial cell layer covering the intestinal villi 
(micrometers) were determined using the OPS method in 5 separate fields by means of a 
computer-assisted image analysis system (IVM Pictron Ltd, Hungary)(see above). 
In Study 2, analysis of morphological injury to the same ileal biopsies was performed on 
slides stained with hematoxylin-eosin in coded slides in a blinded fashion. Measurements 
of the height of different portions of the mucosa were conducted with a computer-assisted 
image analysis system (IVM Pictron, Budapest, Hungary). The extent of mucosal damage 
was determined on the basis of (1) villus height – total mucosal height ratio (%) as well as 
(2) villus height – crypt height ratio (%); these were determined for each villus of the 
current slide (at 3–5 high power fields at 4x magnification). Villus tip injury was also 
assessed using a modified version of Chiu’s method for each villus of the current slide (at 
4–7 high power fields at 10x magnification) (Chiu CJ 1970). 
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3.13. Statistical analyses 
In both studies, data analysis was performed using a statistical software package (SigmaStat 
13.0 version for Windows, Jandel Scientific, Erkrath, Germany) with non-parametric 
methods. Normality was tested with the Shapiro–Wilk test. Friedman’s repeated measures 
analysis of variance on ranks was applied within the groups. Time-dependent differences 
from the baseline were assessed with Dunn’s method. Differences between groups were 
analyzed with the Kruskal–Wallis (one-way analysis of variance on ranks) test, followed 
by Dunn’s method for pairwise multiple comparison. Median values, and 75th and 25th 
percentiles are illustrated in figures. Results were considered significant at P < 0.05 value. 
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4. RESULTS  
 
Study 1 
4.1. Macrohemodynamic effects of IPC during SBTX 
MAP decreased significantly during the reperfusion phase, with no differences in this 
parameter between the SBTX and IPC+SBTX groups (data not shown). Similarly, a 
significant cardiac index (CI) reduction was noted in the SBTX group during the 
reperfusion phase as compared to the baseline value or to the data of the sham-operated 
group. IPC before SBTX attenuated this change, and the improvement in CI was significant 
at 60 min and 240 min after reperfusion (Figure 3). In a comparison with the preharvesting 
level, a significant reduction in SMA blood flow was observed in the SBTX group 
throughout the entire reperfusion period, while IPC stabilized SMA blood flow at a 
significantly higher level, reaching similar values to those of the sham-operated group 
(Figure 4). 
 
Figure 3. Changes in cardiac index in animals subjected to small bowel transplantation (SBTX) in 
the presence and absence of ischemic preconditioning (IPC). Measurements were performed at 
baseline and hourly during a 240 min reperfusion period after 60 min of cold ischemia and at 
matching time points in sham-operated animals (not subjected to ischemia). Median values as well 
as 25th and 75th percentiles are indicated. Time-dependent differences from the baseline were 
assessed with Dunn’s method. Differences between groups were analyzed with the Kruskal–Wallis 
(one-way analysis of variance on ranks) test, followed by Dunn’s method for pairwise multiple 
comparison. X P < 0.05 versus baseline values, # P < 0.05 versus sham-operated group, $ P < 0.05 
between SBTX and IPC + SBTX groups. 
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Figure 4. Changes in superior mesenteric artery flow in animals subjected to small bowel 
transplantation (SBTX) in the presence and absence of ischemic preconditioning (IPC). 
Measurements were performed at baseline and hourly during a 240 min reperfusion period after 60 
min of cold ischemia and at matching time points in sham-operated animals (not subjected to 
ischemia). Median values as well as 25th and 75th percentiles are indicated. Time-dependent 
differences from the baseline were assessed with Dunn’s method. Differences between groups were 
analyzed with the Kruskal–Wallis (one-way analysis of variance on ranks) test, followed by Dunn’s 
method for pairwise multiple comparison. X P < 0.05 versus baseline values, # P < 0.05 versus 
sham-operated group, $ P < 0.05 between SBTX and SBTX + IPC groups.  
 
4.2. Effects of IPC on microcirculatory inflammatory reactions during SBTX 
For technical reasons, IVM observations could not be performed before graft harvesting, 
and the baseline data for this parameter are therefore missing. The number of leukocyte-
endothelial cell interactions was significantly higher after SBTX than in the sham-operated 
group. Reperfusion was followed by steady, approximately 70% primary (rolling) and an 
increasing number of secondary (sticking) leukocyte-endothelial cell interactions in the 
postcapillary venules of the mesentery. IPC significantly reduced the percentages of rolling 
(Figure 5) and the number of firmly adhered white blood cells as well (Figure 6). 
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Figure 5. Changes in leukocyte rolling in ileal postcapillary venules of animals subjected to small 
bowel transplantation (SBTX) in the presence and absence of ischemic preconditioning (IPC). 
Measurements were performed hourly during a 240 min reperfusion period after 60 min of cold 
ischemia and at matching time points in sham-operated animals (not subjected to ischemia). Here, 
plots demonstrate the median (horizontal line in the box), and the 25th (lower whisker) and 75th 
(upper whisker) percentiles. Time-dependent differences from the baseline were assessed with 
Dunn’s method. Differences between groups were analyzed with the Kruskal–Wallis (one-way 
analysis of variance on ranks) test, followed by Dunn’s method for pairwise multiple comparison. 
X P < 0.05 within the groups versus R60’ values, # P < 0.05 versus sham-operated group. 
 
 
Figure 6. Changes in number of adherent leukocytes in ileal postcapillary venules of animals 
subjected to small bowel transplantation (SBTX) in the presence and absence of ischemic 
preconditioning (IPC). Measurements were performed hourly during a 240 min reperfusion period 
after 60 min of cold ischemia and at matching time points in sham-operated animals (not subjected 
to ischemia). Here, plots demonstrate the median (horizontal line in the box), and the 25th (lower 
whisker) and 75th (upper whisker) percentiles. Time-dependent differences from the baseline were 
assessed with Dunn’s method. Differences between groups were analyzed with the Kruskal–Wallis 
(one-way analysis of variance on ranks) test, followed by Dunn’s method for pairwise multiple 
comparison. X P < 0.05 within the groups versus R60’ values, # P < 0.05 versus sham-operated 
group. 
 
4.3. Microcirculatory effects of IPC during SBTX 
SBTX and reperfusion induced a slight decrease in RBCV in the arterioles and venules of 
the villi. After IPC, there was no significant difference in these parameters as compared 
with the corresponding values in the SBTX group (data not shown). The villus capillary 
perfusion, quantified by FCD, was significantly decreased during reperfusion in the SBTX 
group, while this parameter stabilized at close to the control level in the IPC+SBTX group 
(Figure 7).  
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Figure 7. Changes in functional capillary density in capillaries of the ileal longitudinal muscle layer 
in animals subjected to small bowel transplantation (SBTX) in the presence and absence of ischemic 
preconditioning (IPC). Measurements were performed at t= –60 min and hourly during a 240 min 
reperfusion period after 60 min of cold ischemia and at matching time points in sham-operated 
animals (not subjected to ischemia). Here, plots demonstrate the median (horizontal line in the box), 
the 25th (lower whisker) and 75th (upper whisker) percentiles. Time-dependent differences from the 
baseline were assessed with Dunn’s method. Differences between groups were analyzed with the 
Kruskal–Wallis (one-way analysis of variance on ranks) test, followed by Dunn’s method for 
pairwise multiple comparison. X P < 0.05 within the groups versus R-60’ values, # P < 0.05 versus 
sham-operated group, $ P < 0.05 between SBTX and SBTX + IPC groups.  
 
4.4. Effects of IPC on enterocyte injury during SBTX 
The epithelial thickness, a marker of mucosal epithelial injury and epithelial integrity, 
decreased significantly and progressively during reperfusion after SBTX, compared to the 
baseline value or to the data of the sham-operated group. The epithelial thickness in the 
IPC+SBTX group was reduced at 60 min relative to baseline, but thereafter it was 
unchanged, suggesting less severe epithelial structural damage (Figure 8). 
 
 
Figure 8. Changes in epithelial thickness of the small intestinal villi in animals subjected to small 
bowel transplantation (SBTX) in the presence and absence of ischemic preconditioning (IPC). 
Measurements were performed at t= –60 min, and hourly during a 240 min reperfusion period after 
60 min of cold ischemia and at matching time points in sham-operated animals (not subjected to 
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ischemia). Here, plots demonstrate the median (horizontal line in the box), the 25th  (lower whisker) 
and 75th (upper whisker) percentiles. Time-dependent differences from the baseline were assessed 
with Dunn’s method. Differences between groups were analyzed with the Kruskal–Wallis (one-
way analysis of variance on ranks) test, followed by Dunn’s method for pairwise multiple 
comparison. X P < 0.05 within the groups versus R-60’ values, # P < 0.05 versus sham-operated 
group, $ P < 0.05 between SBTX and SBTX + IPC groups.  
 
4.5. Effects of IPC on MC degranulation during SBTX 
No significant differences in mucosal MC degranulation were detected between the 
different experimental groups during baseline (Figure 9). In the SBTX group, cold ischemia 
alone caused significant increases in this parameter at the end of reperfusion. The cold 
ischemia-induced changes were significantly lower in the IPC+SBTX group at the end of 
reperfusion. 
 
Figure 9. Changes in mast cell degranulation in ileal samples from animals subjected to small 
bowel transplantation (SBTX) in the presence and absence of ischemic preconditioning (IPC). 
Samples were taken at baseline and at 240 min of reperfusion after a 60 min of cold ischemia and 
at matching time points in sham-operated animals (not subjected to ischemia). Here, plots 
demonstrate the median (horizontal line in the box), the 25th (lower whisker) and 75th (upper 
whisker) percentiles. Time-dependent differences from the baseline were assessed with Dunn’s 
method. Differences between groups were analyzed with the Kruskal–Wallis (one-way analysis of 
variance on ranks) test, followed by Dunn’s method for pairwise multiple comparison. X P < 0.05 
within the groups versus baseline values, # P < 0.05 versus sham-operated group, $ P < 0.05 
between SBTX and SBTX + IPC groups.  
 
Study 2 
4.6. Effects of 7-nitroindazole (7-NI) on IPC-induced macrohemodynamic changes 
during bowel IR 
Neither 7-NI nor IPC caused any changes in the SMA flow during the preischemic period 
(Figure 10). Ischemia caused an abrupt decrease (due to zero flow during occlusion in the 
affected intestinal area) and early reperfusion (as measured at the 5th min) a temporary 
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increase in this parameter (hyperemia) in all of the groups under examination. During later 
stages of reperfusion, no differences in comparison with baseline values were detected. No 
significant differences were present in SMA flow between the groups at any stage of the 
experiment.  
 
Figure 10. Time course of changes in superior mesenteric artery flow during baseline and during 
60 min of SMA occlusion, followed by 120 min of reperfusion (IR group). Further groups of 
animals were also subjected to ischemic preconditioning (IPC) in the presence and absence of 7-
nitroindazole (7-NI) treatment (IPC+IR+7NI and IPC+IR groups, respectively). Here, values are 
indicated as medians + 25th and 75th percentiles. Time-dependent differences from the baseline were 
assessed with Dunn’s method. Differences between groups were analyzed with the Kruskal–Wallis 
(one-way analysis of variance on ranks) test, followed by Dunn’s method for pairwise multiple 
comparison. X P < 0.05 vs baseline. 
 
4.7. Effects of 7-NI on IPC-induced changes in pHi during bowel IR  
No difference in pHi values was detected at baseline; neither 7-NI nor IPC influenced this 
parameter (Figure 11). In response to 60 min of ischemia, however, a steep decrease in pHi 
was detected (P < 0.05) in all of the groups, followed by a gradual recovery. Restoration in 
this parameter appeared to be more rapid in both IPC groups as pHi values were 
significantly higher than in the IR group during the 30th–90th min of reperfusion. At the end 
of reperfusion (reperfusion 120 min), pHi values were significantly higher only in the 
IPC+IR group than those in the test ischemia (IR) group. 
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Figure 11. Time course of changes in intramucosal pH during baseline and during 60 min of SMA 
occlusion followed by 120 min of reperfusion (IR group). Further groups of animals were also 
subjected to ischemic preconditioning (IPC) in the presence and absence of 7-nitroindazole (7-NI) 
treatment (IPC+IR+7NI and IPC+IR groups, respectively). Here, values are indicated as medians + 
25th and 75th percentiles. Time-dependent differences from the baseline were assessed with Dunn’s 
method. Differences between groups were analyzed with the Kruskal–Wallis (one-way analysis of 
variance on ranks) test, followed by Dunn’s method for pairwise multiple comparison. X P < 0.05 
vs baseline, # P < 0.05 vs IR. 
 
4.8. Effects of 7-NI on IPC-induced changes in small bowel motility during bowel IR  
Small bowel motility was not influenced by 7-NI alone or IPC at baseline, but a transiently 
reduced motility was observed in the 7-NI-treated group immediately after the IPC 
procedure (Figure 12); this vanished in 30 min (just before the beginning of ischemia). 
Ischemia alone did not induce any significant changes in this parameter, but the early 
reperfusion phase (30 min of reperfusion) was associated with an increased intestinal 
motility. This intestinal hypermotility was prevented completely by IPC (to a similar extent 
in both the vehicle- and 7-NI-treated groups), and at the 60th min of reperfusion, even lower 
motility values were detected than those seen at baseline. By the end of 2 hours of 
reperfusion, the motility index was normalized in all of the groups.  
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Figure 12. Time course of changes in motility index during baseline and during 60 min of SMA 
occlusion, followed by 120 min of reperfusion (IR group). Further groups of animals were also 
subjected to ischemic preconditioning (IPC) in the presence and absence of 7-nitroindazole (7-NI) 
treatment (IPC+IR+7NI and IPC+IR groups, respectively). Here, values are indicated as medians + 
25th and 75th percentiles. Time-dependent differences from the baseline were assessed with Dunn’s 
method. Differences between groups were analyzed with the Kruskal–Wallis (one-way analysis of 
variance on ranks) test, followed by Dunn’s method for pairwise multiple comparison. X P < 0.05 
vs baseline, # P < 0.05 vs IR. 
 
4.9. Effects of 7-NI on IPC-induced changes in plasma NOx levels during bowel IR  
In the IR group, no significant changes in NOx values were detected at any phase of the 
experiments (Figure 13). A temporary increase was observed in the vehicle-treated IPC 
group in blood samples taken before the beginning of ischemia and in both IPC groups at 
the beginning (at 15 min) of reperfusion. This IPC-induced increase in NOx levels, 
however, was missing in the 7-NI-treated IPC+IR group; furthermore, a marked increase 
in this parameter was seen at the last time point (120th min) of reperfusion. 
 
Figure 13. Time course of changes in plasma nitrate/nitrite levels (NOx) during baseline and during 
120 min of reperfusion after a 60-min of SMA occlusion (IR group). Further groups of animals 
were also subjected to ischemic preconditioning (IPC) in the presence and absence of 7-
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nitroindazole (7-NI) treatment (IPC+IR+7NI and IPC+IR groups, respectively). Here, values are 
indicated as medians + 25th and 75th percentiles. Time-dependent differences from the baseline were 
assessed with Dunn’s method. Differences between groups were analyzed with the Kruskal–Wallis 
(one-way analysis of variance on ranks) test, followed by Dunn’s method for pairwise multiple 
comparison. X P < 0.05 vs baseline, # P < 0.05 vs IR. 
 
4.10. Effects of 7-NI on IPC-induced changes in ileal NOS activities during bowel IR  
Ca2+-independent and Ca2+-dependent NOS activities were not significantly different 
between the groups under examination at baseline (Figure 14A–B). As for Ca2+-
independent NOS (iNOS) activity, no statistically significant changes were detected 
throughout the entire experimental period in any of the groups (Figure 14B). In the IR 
group, Ca2+-dependent NOS activity showed no changes during any phase of the entire 
examination period either. In the vehicle-treated IPC group, however, a marked increase in 
Ca2+-dependent NOS activity was found at the 15th min of reperfusion, but this increase 
was not present in the 7-NI-treated group. 
 
Figure 14. Changes in constitutive NO synthase (Ca2+-dependent NOS, Panel A) and in inducible 
NO synthase (Ca2+-independent NOS, Panel B) activities in the affected ileal segment during 
baseline, and at 15 min and 120 min of reperfusion (IR). Further groups of animals were also 
subjected to ischemic preconditioning (IPC) in the presence and absence of 7-nitroindazole (7-NI) 
treatment (IPC+IR+7NI and IPC+IR groups, respectively). Here, plots demonstrate the median 
(horizontal line in the box), and the 25th (lower whisker) and 75th (upper whisker) percentiles. Time-
dependent differences from the baseline were assessed with Dunn’s method. Differences between 
groups were analyzed with the Kruskal–Wallis (one-way analysis of variance on ranks) test, 
followed by Dunn’s method for a pairwise multiple comparison. X P < 0.05 vs baseline, # P < 0.05 
vs IR. 
 
4.11. Effects of 7-NI on IPC-induced changes in ileal MPO activity during bowel IR  
The baseline MPO activities were similar in the different groups (Figure 15), but significant 
increases were seen at the 15th and 120th min of reperfusion in the IR group and at the 15th 
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min of reperfusion in the 7-NI+IPC+IR groups. As compared to the IR groups, a significant 
reduction in MPO activity was in evidence in the IPC+IR group at both time points of 
reperfusion under examination.  
 
Figure 15. Changes in leukocyte accumulation (myeloperoxidase activity, MPO) in the affected 
ileal segment during baseline, at 15 min and 120 min of reperfusion (IR). Further groups of animals 
were also subjected to ischemic preconditioning (IPC) in the presence and absence of 7-
nitroindazole (7-NI) treatment (IPC+IR+7NI and IPC+IR groups, respectively). Here, plots 
demonstrate the median (horizontal line in the box), and the 25th (lower whisker) and 75th (upper 
whisker) percentiles. Time-dependent differences from the baseline were assessed with Dunn’s 
method. Differences between groups were analyzed with the Kruskal–Wallis (one-way analysis of 
variance on ranks) test, followed by Dunn’s method for pairwise multiple comparison. X P < 0.05 
vs baseline, # P < 0.05 vs IR. 
 
4.12. Effects of 7-NI on IPC-induced changes in mucosal injury and MC degranulation 
during IR 
MC degranulation or mucosal injury was not present at baseline in any of the groups 
(Figures 16A–D, 17A–B and 18A). 
Fifteen minutes of reperfusion after a 60-min SMA occlusion caused a significant increase 
in MC degranulation (Figures 16A and 17C–D) and in mucosal injury (as evidenced by 
loss of enterocyte integrity and subepithelial changes) (see details in legend for Figures 17–
18) and a reduction in mucosal thickness (Figure 16C–D) in the IR and IPC+IR+7NI 
groups. These changes were exacerbated only moderately by the end of the observation 
period (120 min of reperfusion). In the IPC+IR group, however, a significantly smaller 
extent of both MC degranulation and histological injury were observed than in the other 
groups (Figures 16 and 18C).  
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Figure 16. Changes in mast cell degranulation (Panel A), mucosal histological injury according to 
Chiu’s grade (Panel B) and mucosal height (as expressed as villus/crypt height ratio, Panel C, and 
villus/total mucosa height ratio, Panel D) in samples taken from the affected ileal segment during 
baseline, at 15 min and 120 min of reperfusion (IR). Further groups of animals were also subjected 
to ischemic preconditioning (IPC) in the presence and absence of 7-nitroindazole (7-NI) treatment 
(IPC+IR+7NI and IPC+IR groups, respectively). Here, plots demonstrate the median (horizontal 
line in the box), and the 25th (lower whisker) and 75th (upper whisker) percentiles. Time-dependent 
differences from the baseline were assessed with Dunn’s method. Differences between groups were 
analyzed with the Kruskal–Wallis (one-way analysis of variance on ranks) test, followed by Dunn’s 
method for pairwise multiple comparison. X P < 0.05 vs baseline, # P < 0.05 vs IR. 
  
38 
 
 
Figure 17. Representative micrographs showing mucosal mast cells stained with Alcian blue and 
Safranin O at lower (Panels A and C; bar denotes 200 µm) and higher magnifications (Panels C and 
D) (bar denotes 50 µm). Please note intact intracellular granules (Panel B) and a loss of intracellular 
granules and stained material dispersed diffusely and extracellularly as signs of mast cell 
degranulation at the 120th min of reperfusion in the ischemia/reperfusion group (Panel D). 
  
Figure 18. Representative micrographs of the ileal mucosa stained with hematoxylin and eosin 
staining at baseline (Panel A) and at 120 min of reperfusion in the IR group (Panel B), the IPC+IR 
group (Panel C) and the IPC+IR+7NI group (Panel D). Panels B and D demonstrate massive 
epithelial lifting down the side of villi, denuded villi, increased cellularity of the lamina propria, 
hemorrhage and the end of the finger-like appearance of villous structures. Panel C displays the 
development of subepithelial Gruenhagen’s space at the apex of the villus, capillary congestion and 
extension of the subepithelial space with a lifting of the epithelial layer from the lamina propria. 
The bar denotes 200 µm in all figures.  
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5. DISCUSSION 
 
5.1. Alleviating effects of IPC on cold and warm ischemia-induced circulatory and 
morphological injury of the small intestine in dogs 
 
Issues of clinical relevance  
The present studies were focused on an examination and modulation of the consequences 
of SBTX, which is a typical manifestation of surgically induced bowel ischemia. At the 
time of publication, our Study 1 was the first to provide a description of the 
microcirculatory consequences of IPC with SBTX. We observed the microcirculation 
directly with 2 different methods of intravital microscopy in a large animal (dog) model of 
SBTX. Cold graft perfusion, harvesting and vascular anastomoses were performed during 
autotransplantation to mimic clinical conditions but to exclude possible immunological 
complications (hence observing changes related to IR only). In this context, the therapeutic 
potential of IPC was tested and the role of nNOS examined in a surgically induced IR model 
(in Study 2). 
Two manifestations of bowel IR examined in these studies 
In Study 1, IPC was induced in an intestinal transplantation model, whereas in Study 2, the 
effects and mechanisms of IPC were examined in an bowel IR setting. There are certain 
differences between cold ischemia/SBTX and warm IR, which include (extrinsic) 
denervation of the bowel segment, transsection of the bowel walls and that of vessels and 
the lymphatic network, a somewhat longer duration of the operations and some protection 
which is derived from the cooling process in the case of SBTX. Although the examination 
period during reperfusion was somewhat different, we intended to compare findings for 
SBTX with those for IR only (as follows).  
Macrocirculatory differences 
One of the differences we detected between the SBTX and IR models is the different pattern 
of SMA blood flow changes. Firstly, a characteristic hyperemic flow response was 
observed in the IR groups at the onset of reperfusion, but it was not present in the SBTX 
groups (which underwent the same duration of ischemia). Secondly, IR was not 
accompanied by a considerable SMA flow reduction during reperfusion, whereas SBTX 
was accompanied by a severe postischemic deterioration. Both the absence of the 
hyperemic flow reaction and the reduced blood flow during reperfusion can be explained 
as a consequence of SBTX-induced denervation and its hemodynamic effect on local 
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vascular regulation. Local (mesenteric) flow changes also showed parallel changes with 
those of CI (during the entire reperfusion period). Since there were no considerable changes 
in heart rate, cardiac preload (central venous pressure) or afterload (mean arterial pressure) 
observed (data not shown), probably a depressed heart contractility may mostly account for 
the reduced CI in the SBTX model. Mesenteric ischemia affects a considerably large 
portion of the vascular bed; therefore, the remote effects (i.e. impaired cardiac function), 
which was previously interpreted as a “release of cardiodepressant substances” (Haglund 
U 1993) from the previously ischemic splanchnic vascular bed (or microvasculature), can 
be suspected. Another explanation behind these findings may originate in a 
vasoconstrictory reaction within the mesenteric microvasculature (Wolfárd A 2002). 
Interestingly, most of these macrohemodynamic changes were beneficially influenced by 
IPC (restoring the SBTX/reperfusion-induced deterioration in both SMA flow and CI near 
the control values).  
Microcirculatory differences 
As shown by intravital microscopy, impairment in microcirculatory blood supply is a 
characteristic consequence of both IR and SBTX (Gonzalez AP 1994; Wolfárd A 2002; 
Lautenschläger I 2018). Based on the present results, a long-term deterioration in 
microcirculatory blood flow is suspected in both models. In Study 1, there was a significant 
reduction in FCD, which was greatly ameliorated by IPC in the cold ischemia model of 
SBTX, whereas in Study 2, pHi, which provides an indirect measure of tissue oxygenation 
and therefore an estimation of the efficacy of microcirculatory blood flow, showed 
remarkably similar changes. It is important to note that IPC exerted similar protection 
(independently of the differences in cold/warm ischemia or denervation).  
Both IR and SBTX induce marked enhancement of PMN-mediated reactions (see Gonzalez 
AP 1994; Cicalese L 1996; Wolfárd A 2002; Zhang XQ 2005), and here IPC induced 
similar protection in both models (PMN-endothelial interaction in Study 1 and MPO 
activity in Study 2). As shown by Carmody et al., reduced PMN infiltration improved 
outcome of both warm IR and SBTX (with cold ischemia) in selectin knock out animals 
(Carmody IC 2004). In response to warm IR, increased MPO values were observed as early 
as the 15th min of reperfusion in our model, but this phenomenon was observed similarly 
early by others after 6–24 hrs of cold ischemia in rats (Massberg S 1998; Cao B 2005). 
Nonetheless, the duration of cold ischemia seems to influence the extent of adhesion 
molecule-dependent enhancement of PMN-endothelial interactions (Preissler G 1998; 
Massberg S 1998; Schramm R 2007). With SBTX, IPC was shown to provide similar 
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prevention of tissue infiltration of PMNs (de Oca 1999). Although we did not examine it 
here, hypoxia-induced factor-1, a suspected mediator mechanism of IPC, is influenced by 
a PMN respiratory burst, which also counteracts with epithelial integrity (Karhausen J 
2004; Colgan SP 2015). Furthermore, PMN transmigration during acute mucosal 
inflammation causes a transient increase in epithelial permeability through a protein kinase 
A-dependent mechanism (Haskó G 2008; Colgan SP 2012, 2015). It was suggested by de 
Groot H et al. that differences may occur in the inflammatory response following warm and 
cold ischemia: cold ischemia has been shown to affect endothelial cells to a greater extent 
than warm ischemia (via macrophages and neutrophils, and pro-inflammatory cytokine-
dependent mechanism) (de Groot H 2007).  
Potential denervation-related events 
Denervation occurring during SBTX may also represent an important issue. Although the 
intrinsic nerve plexuses remain unaffected, external (e.g. sympathetic and parasympathetic) 
innervation of the bowel is lost, thus possibly also contributing to intestinal dysmotility 
(Ballinger WF 1962). Interstitial Cajal cells were found to be temporarily impaired, and the 
myenteric and submucosal ganglia are also morphologically altered after SBTX. However, 
the spontaneous contractile function recovers within approximately one month (Takayama 
I 2000; Matsuura T 2007), while slow wave frequency recovers much later (within 18 
months) (Quigley EM 1998). It has been suggested that intestinal dysmotility leads to 
bacterial overgrowth due to the stasis of bowel contents in the long run (Nieuwenhuijs VB 
1998). In other studies, the motility index decreased at the proximal colon after extrinsic 
denervation (Morita H 2012) and exogenous NO caused a dose-dependent inhibition of 
spontaneous and basal contractile activity in intestinal muscle strips (Zyromski NJ 2005). 
In the present study, intestinal motility with SBTX was not examined, and apart from a 
transient postischemic increase in ileal motility, no further changes were in evidence in 
response to IR in the early reperfusion phase either.  
Changes related to MC activation 
In both of our studies (in the presence of both cold and warm IR), a similar extent of MC 
degranulation was in evidence. MC degranulation is known to be involved in IR injury in 
the rat small intestine (Boros M 1995), also modulating permeability chances both in dogs 
(Szabó A 1997) and rats (Andoh A 1999). MCs facilitate mesenteric afferent signaling 
during acute intestinal ischemia as well (Jiang W 2011). MC stabilizers (Na-cromoglycate 
and ketotifen) reduce bowel IR injury, e.g. Chiu’s score (Hei ZQ 2007), improve skin flap 
survival, also influencing MPO (Cordeiro PG 2000) in rats, and ameliorate PMN-
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endothelial interactions in the feline and rat bowel (Kanwar S 1994d; Kalia N 2005). MC 
degranulation appears to be free radical-dependent in the rat intestine, since SOD and 
catalase reduce this reaction (Kanwar S 1994c), but the role of endothelin also seems to be 
involved in this process (Szalay L 2000). MC stabilization likewise attenuates intestinal IR 
injury by down-regulating endothelin-1 and MPO levels in mice (Gan X 2013). MC-
derived mediators were shown to be involved in the L-NAME-induced enhancement of 
epithelial permeability seen in the rat small intestine in vivo (Kanwar S 1994a). Although 
the results are debated, degranulation of connective tissue-type MCs also seems to be 
mediated by NO (van Overveld FJ 1993; Iikura M 1998). Interestingly, the positive effect 
of IPC was dependent on MC-dependent mediator release in the small bowel (Xing D 2014) 
and in the heart (Parikh V 1998) in rats. MC stabilization has been shown to increase 
survival in rats subjected to intestinal IR (Kalia N 2005).  
The involvement of MCs in the cold IR-related processess has also been implicated 
elsewhere. Specifically, MCs may also be involved in acute rejection of renal allografts 
(Ehara T 2003) and at orthotopic liver transplantation (Yang M 2014). Through the 
secretion of both pro- and antiinflammatory mediators, MCs also influence the course and 
outcome in lung transplantation (Jungraithmayr W 2015). Another aspect is the activatory 
effect of MCs on dentritic cells, which may have implications in transplantation biology 
(Goldstein DR 2005; Land WG 2006, 2007). In our studies, a similar degree of MC 
degranulation were in evidence in response to IR and SBTX, and IPC alleviated these 
reactions to a similar extent. Based on the present findings, the role of MC-related processes 
in the mechanisms of IPC cannot be ruled out. 
Morphological injury 
In the present studies, mucosal injury showed a classical pattern and reached a similar 
extent in both studies and IPC again showed similar protection, but examination of the 
exact mechanism (e.g. whether it was caused by necrosis or apoptosis) was outside the 
scope of the studies. It has been shown that both pHi changes (Iwanami K 1998), and the 
extent of PMN transmigration show a good correlation with the overall severity of intestinal 
histological injury (Nusrat A 1997; Nash S 1987; Ginzberg HH 2001). It was suggested by 
Rauen U et al., however, that cold storage may induce apoptosis per se in several cell types 
(e.g. endothelial cells, hepatocytes and renal tubular cells) via cold-induced accumulation 
of iron ions, which triggers an activation of mitochondrial apoptotic reactions (via their 
involvement in catalizing ROS formation) (Rauen U 2004). A similar reaction was 
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demonstrated in the rat liver (Ikeda T 1992; Huet PM 2004), but examination of the 
reactions of the cold IR-induced apoptosis did not represent an aim of the present studies. 
Conclusions of Study 1 
Using intravital microscopic and conventional histological methods, our present studies 
demonstrated that the reperfusion phase after warm IR and SBTX is associated with a 
similar extent of microcirculatory deterioration, a remarkably early and similar degree of 
PMN accumulation and MC degranulation as well as mucosal injury. The data also showed 
that these changes could effectively be ameliorated by IPC in both models. Based on the 
results of hemodynamic assessment, however, differences between warm and cold IR was 
also suspected (i.e. differeces in postischemic flow changes), but the effect of IPC appeared 
to be similar. 
 
5.2. The role of neuronal nitric oxide synthase in intestinal IPC-induced protection 
against warm bowel ischemia in dogs 
 
Our second study confirms the results of previous studies on the protective effect of IPC in 
the intestine (Hotter G 1996; Ferencz A 2002; Sileri P 2004; McCallion K 2000; Yang B 
2018), but the involvement of nNOS in IPC-induced intestinal protection was first 
demonstrated here. This conclusion was derived from findings where inhibition of nNOS 
with 7-NI antagonized the protection provided by IPC in numerous respects (pHi, intestinal 
motility, PMN accumulation, MC degranulation and morphological injury).  
Time course of mucosal injury during reperfusion 
Reperfusion injury of the bowel affects different structural elements of the bowel in a 
particular sequence. The early reperfusion phase affects the integrity of the enterocyte 
lining and the rest of the mucosa relatively early, followed by injury to the muscle and 
neuronal structures (Pontell L 2011). In our study, the IPC-induced protection of the 
intestinal mucosal barrier (in particular the villus tips) developed as early as the 15th min 
of reperfusion, which persisted over the 120-min reperfusion period under examination. In 
other studies (performed on rats), IPC exerted marked protection of intestinal mucosa (in 
particular villus tips), which manifests in reduced mucosal permeability (McCallion K 
2000; Maretta M 2012) and apoptosis (Sileri P 2004) in the early reperfusion phase (<120 
min) and in enhanced IPC-induced mucosal regeneration in the later phase (Maretta M 
2012). The mechanisms of protection provided by IPC in the intestine were strongly linked 
to oxidative stress (MDA and TNF-α release: Ferencz A 2002; endothelial activation and 
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adhesion molecule release: Camprodon RA 2014 and Ji YY 2015) but were also attributed 
to NO-dependent mechanisms (Hotter G 1996; Sola A 2001). A transient peak in NO 
release was detected during the early postischemic phase in the rat intestine (Hotter G 
1996), and this phenomenon was also observed if IR was preceded by IPC (Watanabe T 
2007).  
NOS activation during reperfusion 
IR, however, has also been shown not only to reduce, but also to trigger nNOS expression 
at early stages of reperfusion (Lai CH 2017) even as early as 5 min of reperfusion in vitro 
(in Guinea pigs) (Giaroni C 2013) or after 3 h of reperfusion in vivo in the rat jejunum (Lai 
CH 2017). The effect of IPC on the expression and function of nNOS was first examined 
here (at least to our knowledge). Specifically, a nNOS-dependent NO release can be 
presumed in response to IPC as levels of NO metabolites in the venous effluent of the 
intestine were effectively reduced when the specific NOS inhibitor 7-NI was administered 
before IPC. At the beginning (15th min) of reperfusion, the IPC-induced increase in Ca2+-
dependent NOS activity was also prevented by 7-NI. Further, we saw a marked increase in 
NOx metabolites occurring in the late phase of reperfusion (which is rather unexpected); 
this can probably be explained by non-enzymatic production of NO (Zweier JL 1995) 
resulting from hypoxia via impairment of the microcirculation in the postischemic bowel 
tissue. It remains unclear, however, why these changes did not manifest in alterations in 
intestinal motility or microcirculation (see later). 
The role of nNOS (similarly to that of NO in general) is usually found, however, to be 
rather controversial (in relation to both reperfusion and IPC) by others. Rivera LR et al. 
have also discussed this issue and suspected that, despite some extent of free radical 
production derived from nNOS, this NOS isoform has a predominantly protective role of 
nNOS against intestinal reperfusion injury (with respect to bowel muscle contractility and 
PMN accumulation, Rivera LR 2012). The same group found that nitrosative stress takes 
place mostly in a later phase of reperfusion in the enteric nerve system (Rivera LR 2011b) 
and in the muscle layer, which is obviously preceded by damage to the mucosa (Pontell L 
2011). Furthermore, genetic ablation of the nNOS gene worsens the IR-induced bowel 
injury (inflammatory infiltration and motility) (Rivera LR 2012). So far, the role of nNOS 
in IPC has been examined to a lesser extent. Despite the previously observed debates (Altay 
T 2004; Beck PL 2004; Qu XW 2005; Iijima H 2005), the contribution of nNOS to IPC-
induced postischemic reactions is obviously positive in our study. Although the role of 
nNOS in the mechanisms of IPC was not examined elsewhere in the intestine, nNOS was 
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also found to be protective in other organs, such as in heart IPC (both in vitro and in vivo) 
(Barua A 2010). This protection in the heart involves reduced oxidative/nitrosative stress, 
and the positive effects of IPC are lost after nonspecific NOS inhibition and in nNOS 
knockout animals (Lu XM 2009). Furthermore, the post-translational modification and 
modulatory effect of IPC on nNOS activity was also demonstrated in a cerebral ischemia 
model (Wang M 2016). Here, we could not examine the effect of nNOS inhibition on IR-
induced changes (in adherence to the 3Rs approaches in animal research), but others also 
demonstrated a predominantly protective role of nNOS against intestinal reperfusion injury 
(with respect to bowel muscle contractility and PMN accumulation) (Rivera LR 2012). 
Bowel motility changes during reperfusion 
It appears that bowel IR may cause blood supply-dependent and/or nitrosative stress-
mediated neuronal injury of the bowel, but this usually occurs after relatively long ischemic 
challenges (also depending on the species) and typically develops at later stages of 
reperfusion (Calcina F 2005; Rivera LR 2011b; Taha MO 2012; Palombit K 2013). Based 
on examinations of bowel motility in the present study, we found no major sign of 
neurogenic dysfunction of the bowel within the observed reperfusion period; furthermore, 
we noted a temporary postischemic enhancement in this regard at an early stage of 
reperfusion. On the other hand, since 7-NI was administered before IPC, we had a chance 
to assess its direct effects (independently of IR). Interestingly, this manifested in an 
immediate, but temporary decrease in bowel motility. Since nNOS immunoreactive 
myenteric neurons are inhibitory motoneurons and descending interneurons, the above 
effect of 7-NI on bowel motility is surprising. It is known that NO, synthesized at a 
peripheral level by nNOS, reduces intestinal motility (as was demonstrated in sheep, for 
instance) (Castro M 2012) via sustained smooth muscle hyperpolarization; this causes 
inhibition of spontaneous motility (Gil V 2010). On the other hand, nonspecific inhibition 
of nNOS reduced gastrointestinal motility not only in our study, but also elsewhere (Calcina 
F 2005; Filpa V 2017), and we found a similar reducing effect of 7-NI on the colon motility 
in a subacute bowel obstruction model as well (Palásthy Z 2006). We also observed a 
temporary increase in bowel motility at the 30th min of reperfusion which was not seen in 
either of the IPC groups. Early postischemic changes in bowel motility was not examined 
by others with similar methods, but reperfusion after a 1-hr segmental ileal ischemia 
followed by 2 hrs of reperfusion was similarly associated with reduction in motility (as 
measured by intestinal transit time); it could be reserved by L-NAME and an NMDA 
receptor antagonism (Calcina F 2005). The effects of IR on motility are usually examined 
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in a longer run, and the results are somewhat controversial. In nNOS knockout animals, 
bowel motility (after 2 h of ischemia) did not decrease at 3 h, but did so at 48 h of 
reperfusion (Rivera LR 2012), while reduced intestinal transit time (i.e. increased motility) 
was observed under similar circumstances after nNOS inhibition (Filpa V 2017). The 
effects of IPC on IR-induced bowel motility changes were only examined in the long term, 
showing that IPC restores the reduced motility caused by 30 min of ischemia followed 6 h 
of reperfusion in rats (Moore-Olufemi SD 2005). In our study, IPC prevented the IR-
induced temporary increase in bowel motility at the early reperfusion phase, and 7-NI had 
no specific effect on this reaction within the examined time frame.  
PMN- and MC-related changes 
Although postischemic mucosa/enterocyte injury is believed to be linked mostly to 
intracellular free radical-mediated processes, bowel IR also induces marked inflammatory 
reactions (e.g. PMN accumulation and MC degranulation); these can also be inhibited by 
IPC (de Oca J 1999; Xing D 2014). Increased PMN accumulation (i.e. increased tissue 
MPO) in the affected intestine after IR was also demonstrated elsewhere as early as 30–60 
min after ischemia in rats (de Oca J 1999; Filpa V 2017). We saw simultaneous early 
increases in both tissue MPO and MC degranulation as early as 15 min after ischemia, 
which were both ameliorated by IPC. Similar, relatively early MPO changes were also 
demonstrated in rats (examined 30–60 min after ischemia) (de Oca J 1999; Unal S 2003; 
Filpa V 2017), and this effect was also present at 6 hrs of reperfusion (Moore-Olufemi SD 
2005). The nNOS dependency of the latter reaction was also proven as inhibition of nNOS 
(or KO) (Rivera LR 2012) reversed this protection. In a cremaster flap model, 7-NI did not 
influence the effect of IPC on PMN-endothelial interactions (4h/2h IR) (Sanz MJ 2001). 
Our study is the first to show that nNOS also plays a role in the mechanism of protection 
provided by IPC in reducing MPO activity in the intestine.  
Interestingly, the positive effect of IPC was also dependent on MC-dependent mediator 
release in the small bowel (Xing D 2014). In our study, however, the IR-induced 
degranulation of MCs was not increased, but rather greatly prevented by IPC, which was 
reversed by 7-NI. It is therefore reasonable to assume that altered MC degranulation is a 
manifestation of reduced inflammatory reactions caused by nNOS in this IPC model, and 
this process may also be involved in mediating the structural injury of the intestinal mucosa. 
Apart from oxidative injury, the integrity of the enterocyte lining is also highly dependent 
on adequate oxygen delivery. Similarly to others (though working with rats) (Jansson L 
2005), our study found evidence of relatively minor IR-induced macrohemodynamic 
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changes, but microvascular perfusion (as estimated indirectly by tonometry) underwent a 
marked and lasting deterioration. The positive effects of IPC on IR-induced deterioration 
of microvascular perfusion, tissue oxygenation and leukocyte-endothelial interaction 
within the microvasculature of the small intestine are in evidence here and in a number of 
other studies (see Study 1; Mallick IH 2005a, 2005b). These reactions were also explained 
with an IPC-induced reduction of intestinal oxidative stress (Ji YY 2015). It appears that 
our study is the first to show that nNOS also plays a role in a more rapid microcirculatory 
recovery after bowel IPC. Since there was also remarkably early evidence of an increase in 
MPO and the appearance of morphological injury in the reperfusion phase in our study, the 
importance of leukocyte-mediated reactions in preserving morphological integrity (as 
another manifestation of nNOS-dependent IPC effects) cannot be ruled out either. 
Conclusions of Study 2 
In the present study, the beneficial effects of intestinal IPC were examined in a relatively 
detailed fashion (with respect to pHi, motility dysfunction, leukocyte accumulation, MC 
degranulation and mucosal injury). Changes in some of the parameters under examination 
(in particular in IPC-induced marked increase in NO availability: e.g. NOx and constitutive 
NOS activity, pHi, and inflammatory and morphological changes) could be 
influenced/reversed by pre-treatment with the nNOS inhibitor 7-NI. Hence, our data 
strongly supports the contribution of intestinal nNOS enzyme in the protective effect of 
IPC against the IR-related acute inflammatory response and morphological injury in the 
small intestine. 
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6. SUMMARY OF NEW FINDINGS 
 
1. Using IVM, our experimental study was the first to demonstrate the beneficial 
postischemic microcirculatory effects of IPC after cold bowel ischemia in a large animal 
model of SBTX. 
2. We have shown similar microcirculatory deterioration, early PMN accumulation, MC 
degranulation and mucosal injury in both IR and SBTX models and have demonstrated 
that these changes can be ameliorated by IPC. The early postischemic intestinal flow 
changes after SBTX are due to cold ischemia and denervation. 
3. IPC before IR induces an acute release of NO and an increase in the Ca2+-dependent 
intestinal NO synthase activity during the early reperfusion phase. 
4. IPC reduces the IR-induced temporary increase in intestinal motility in the early 
reperfusion phase and protects against IR-related acute inflammatory response and 
intestinal damage characterized by amelioration of microcirculation/tissue oxygenation, 
PMN accumulation, MC degranulation and structural injury. 
5. The mechanism of intestinal IPC-induced organ protection is mediated through an effect 
on nNOS-linked NO generation. 
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herence.  Conclusion: IPC improves the macrohemodynam-
ics and the intestinal microcirculation and reduces leuko-
cyte-mediated tissue injury during reperfusion. IPC can be 
an effective tool to limit reperfusion injury during SBTX. 
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 Introduction 
 Small bowel transplantation (SBTX) is the optimal 
treatment modality and the best alternative to total par-
enteral nutrition for patients with short bowel syndrome 
 [1–3] . Although novel immunosuppressive strategies 
have improved the clinical outcome, the survival of grafts 
and patients is still poor and the results do not match the 
success rates of the transplantation of other organs (e.g. 
kidney, liver or heart). This implies that other, nonim-
munological reactions, such as hypoxic damage or isch-
emia and reperfusion play pivotal roles in the postopera-
tive graft dysfunction and damage  [4] . Reperfusion in-
duces a complex phenomenon, including vasoconstric-
tion or leukocyte-endothelial cell interactions, and leads 
to severe tissue injury over and above the ischemic dam-
age  [5–7] . Since the mucosa is the most sensitive part of 
the intestinal structure, mucosal barrier disruption 
quickly leads to bacterial and/or endotoxin translocation 
and septic complications not only after SBTX but also in 
other cases of occlusive or nonocclusive mesenteric isch-
emia  [4] . 
 Key Words 
 Small bowel transplantation   Microcirculation   
Ischemia-reperfusion   Ischemic preconditioning 
 Abstract 
 Background/Aims: Ischemia-reperfusion injury contributes 
to the high complication rate of small bowel transplantation 
(SBTX). Ischemic preconditioning (IPC) protects against re-
perfusion injury in several organs, but the IPC-induced mi-
crocirculatory reaction in the intestine is unknown.  Meth-
ods: We examined the effects of IPC on the macrohemo-
dynamics and graft microcirculation in a canine model of 
SBTX during a 4-hour reperfusion period. In group 1 SBTX 
was performed, in group 2 IPC was induced before graft har-
vesting (ischemia 3 times for 5 min, followed by 10 min of 
reperfusion). Cardiac index and mesenteric blood flow were 
measured, and the mucosal microcirculation, villus epithe-
lial thickness and functional capillary density were moni-
tored by orthogonal polarization spectral imaging. Leuko-
cyte-endothelial cell interactions were monitored in the 
postcapillary venules, with intravital fluorescence microsco-
py.  Results: Reperfusion decreased cardiac index and mes-
enteric blood flow during reperfusion; IPC significantly im-
proved these changes. Reperfusion was accompanied by de-
creased functional capillary density and epithelial thickness 
of the villi and increased leukocyte-endothelial cell interac-
tions. IPC increased functional capillary density, prevented 
epithelial narrowing and reduced leukocyte rolling and ad-
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 The aim to attenuate ischemia-reperfusion (I/R) in-
jury is as old as the recognition of the phenomenon. Var-
ious methods have been proposed and some of them have 
been applied in clinical practice. Ischemic precondition-
ing (IPC) was first described by Murry et al.  [8] in 1986 
and it has subsequently been regarded as a promising tool 
against I/R in many organs. IPC is the phenomenon that 
short periods of ischemia make the tissues resistant to the 
deleterious effects of subsequent, prolonged ischemia. It 
is divided into 2 phases. The acute, transient reaction oc-
curs within minutes (‘classic preconditioning’), involves 
the upregulation of pre-existing defense mechanisms and 
is presumably independent of de novo protein synthesis. 
The other, delayed part (‘second window of protection’) 
requires hours for complete induction, is sustained and 
may require de novo protein synthesis. The underlying 
mechanism has been studied mainly in the myocardium, 
but sufficient data concerning the mechanism of IPC in 
other organs, including the small bowel, are still not 
available. Recently, it has been shown that the IPC-in-
duced amelioration of I/R injury may involve protection 
of the villous microcirculation in rodents  [9] . Although 
the above line of reasoning suggests that an improved 
microcirculation could be closely associated with a better 
tissue homeostasis during SBTX, the relative contribu-
tions of IPC-caused microvascular responses in this set-
ting are unclear. 
 Our present goal was an adequate description of the 
posttransplant microcirculatory changes in a large ani-
mal model of SBTX. To this aim, the inflammatory 
 cellular reactions and perfusion changes in dogs were 
characterized separately by means of conventional fluo-
rescence intravital microscopy and an orthogonal polar-
ization spectral (OPS) imaging technique, respectively. 
Secondly, the therapeutic potential of IPC was investi-
gated during the early reperfusion phase of SBTX. 
 Materials and Methods 
 The experiments were performed in adherence to the NIH 
guidelines for the use of experimental animals. The study was ap-
proved by the Ethics Committee for the Protection of Animals in 
Scientific Research at Szent-Györgyi Albert Medical Center, Uni-
versity of Szeged. 
 Surgical Preparation 
 Three series of experiments were performed on a total of 15 
inbred dogs (Beagle Kennel of the Animal House of the Univer-
sity of Szeged, average weight 15.4 kg) under sodium pentobarbi-
tal anesthesia (30 mg/kg i.v.). The animals were deprived of food, 
but not water, for 24 h prior to the experiments. Endotracheal in-
tubation was applied to facilitate respiration, and the body tem-
perature was maintained at 37  °  C with a homeothermic blanket. 
In aseptic techniques, the right femoral artery and vein were can-
nulated for the measurement of mean arterial pressure (MAP) 
and for fluid and drug administration, respectively. All animals 
received a continuous infusion of Ringer’s lactate at a rate of 10 
ml/kg/h. A Swan-Ganz thermodilution catheter (Corodyn TD-E-
N, 5011-110-7Fr; Braun Melsungen AG, Melsungen, Germany) 
was placed into the pulmonary artery via the left femoral vein, to 
measure cardiac output by thermodilution. 
 In group 1 (n = 5), orthotopic SBTX was performed. Following 
an upper transverse laparotomy, the spleen was removed, and the 
root of the superior mesenteric artery (SMA) and vein was dis-
sected free. The mesentery of the small bowel was divided be-
tween ligations in the distal (ileocolic) and proximal (duodeno-
jejunal) parts and the intestinal wall was transected. The SMA 
was then cannulated with a 7-F polyethylene catheter and the 
small intestine was removed from the abdominal cavity. The in-
testinal graft was perfused with 500 ml chilled (4  °  C) heparinized 
Ringer’s lactate at a perfusion pressure of 100 cm water. The graft 
was stored on ice until the vessels were reanastomosed end-to-end 
with 6/0 running sutures (nonabsorbable polypropylene). After 
60-min cold ischemia, reperfusion was induced and the macro- 
and microhemodynamic changes were observed hourly for 4 h 
after revascularization. 
 In group 2 (n = 5), the experimental protocol was identical to 
that described above, except that an IPC was performed (3 times 
5-min SMA occlusion, followed by 10 min of reperfusion) 60 min 
prior to ischemia induction. 
 Group 3 (n = 5), served as sham-operated control, without 
bowel harvesting. In these animals laparotomy and splenectomy 
were performed and the mesenteric vessels were cannulated for 
hemodynamic measurements. All manipulations were identical 
to those in the other, treated groups, with the exception that the 
bowel was not perfused and harvested. There was no significant 
difference    between    the    3    groups    as    concerns    the    duration   of  
 the   surgical   preparation   or   the cold ischemia time in groups 1 
and 2. 
 Hemodynamic Measurements 
 The central venous pressure and MAP were measured with 
Statham P23Db transducers. The SMA blood flow (SMAF) was 
monitored continuously, using an ultrasonic flow probe (Tran-
sonic Systems Inc., Ithaca, N.Y., USA) placed around the exposed 
SMA. Hemodynamic data were registered with a computerized 
data acquisition system (SPEL Adv Haemosys 2.46, Experimetria 
Ltd., Budapest, Hungary). The cardiac index (CI) was determined 
by a thermodilution technique, using a Cardiostar CO-100 com-
puter (Experimetria Ltd.). Arterial blood gases were regularly 
measured with a blood gas analyzer (AVL, Graz, Austria). 
 Intravital Fluorescence Videomicroscopy 
 The mesenteric microcirculation was analyzed by using an 
epi-illumination technique. An ileal segment with intact neuro-
vascular connections was gently placed on a specially designed 
stage. During the entire in vivo microscopic procedure, the tissue 
was constantly bathed in 37  °  C Ringer’s lactate to avoid drying 
and exposure to ambient air. Leukocyte-endothelial cell interac-
tions in the postcapillary venules of the mesentery were moni-
tored with a high-resolution Zeiss Axiotech Vario 100 HD fluo-
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rescent intravital microscope (100 W HBO mercury lamp, Acro-
plan 20  ! water immersion objective, Ex: 495 nm, Em: 515 nm). 
The microscopic images were recorded by a charge-coupled de-
vice video camera (AVT HORN-BC 12) attached to an S-VHS 
video recorder (Panasonic AG-MD 830) and a personal computer. 
Leukocytes were stained in vivo by means of rhodamine-6G (Mw 
479, Sigma, St. Louis, Mo., USA; 0.2%, 0.1 ml i.v.). Quantitative 
assessment of the microcirculatory parameters was performed 
off-line by frame-to-frame analysis of the videotaped images (Pic-
tron Ltd., Budapest, Hungary) within 5 postcapillary venules per 
animal, including the observation of nonadherent, adherent and 
rolling leukocytes. Adherent leukocytes (stickers) were defined in 
each vessel segment as cells that did not move or detach from the 
endothelial lining within an observation period of 30 s and are 
given as the number of cells per square millimeter of endothelial 
surface, calculated from the diameter and length of the vessel seg-
ment observed, assuming cylindrical geometry. Rolling leuko-
cytes were defined as cells moving at a velocity less than 2/5 of 
that of the erythrocytes in the centerline of the microvessel and 
are given as a percentage of the nonadherent leukocytes passing 
through the observed vessel segment within 30 s. 
 OPS Imaging 
 An intravital OPS technique (Cytoscan A/R, Cytometrics, Pa., 
USA) was used to monitor microvascular perfusion changes in the 
intestinal villi before harvesting and during the reperfusion phase 
after transplantation. The OPS imaging technique utilizes reflect-
ed polarized light at 548 nm, which is the isosbestic point of oxy- 
and deoxyhemoglobin. Since polarization is preserved in reflec-
tion, only photons scattered from relatively deep inside the tissue 
contribute to the images. In this way, a virtual light source is cre-
ated in the tissues so that the vessels appear black. The method is 
suitable for visualizing all hemoglobin-containing structures, 
without the use of a fluorescent dye. A 10 ! objective was intro-
duced into the intestinal lumen through a small enterotomy, on the 
antimesenteric side of the bowel. The objective was connected to a 
light source with flexible cables; thus, this intestinal segment was 
not exteriorized during the study. Quantitative assessment of the 
microcirculatory parameters was performed off-line by frame-to-
frame analysis of the videotaped images. The functional capillary 
density (length of perfused nutritive capillaries per observation 
area (centimeter –1 ), the red blood cell velocity (millimeters/second) 
in the central arterioles and venules of the villi and the thickness 
of the epithelial cell layer covering the intestinal villi (micrometers) 
were determined in 5 separate fields by means of a computer-as-
sisted image analysis system (IVM Pictron  ). All data were ex-
pressed as the means of 5 measurements at each time point. 
 Experimental Protocol 
 The animals were randomly assigned to one or other of the 
experimental groups. After a stabilization period, the basal car-
diovascular parameters were measured for 20 min. Control OPS 
measurements (functional capillary density, epithelial thickness 
and red blood cell velocity) were performed before perfusion. For 
technical reasons (it needs to transport the experimental animal 
beyond the microscope), baseline IVM measurement were not 
performed before perfusion. After these measurements in group 
2, complete SMA occlusion was performed 3 times for 5 min, fol-
lowed by 10 min of reperfusion (IPC). Sixty minutes after IPC, 
perfusion of the graft was performed, and after 60-min cold isch-
emia vascular anastomoses were performed, and reperfusion was 
monitored for 4 h. Leukocyte-endothelial cell interactions were 
monitored hourly by IVM during the 4-hour reperfusion phase. 
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 Fig. 1. Changes in CI in the SBTX (black circles, n = 5), precondi-
tioned SBTX (grey circles, n = 5) and sham-operated (open circles, 
n = 5) groups. Median values and 75th and 25th percentiles are 
given.  a  p  ! 0.05 within the groups versus baseline values,  b  p  ! 
0.05 between the sham-operated and SBTX or SBTX + IPC groups, 
 c  p  ! 0.05 between SBTX and SBTX + IPC groups. 
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 Fig. 2. Changes in SMA flow in the SBTX (black circles, n = 5), 
preconditioned SBTX (grey circles, n = 5) and sham-operated 
(open circles, n = 5) groups. Median values and 75th and 25th 
percentiles are given.  a  p  ! 0.05 within the groups versus baseline 
values,  b  p  ! 0.05 between the sham-operated and SBTX or SBTX 
+ IPC groups,  c  p  ! 0.05 between SBTX and SBTX + IPC groups. 
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 Statistical Analysis 
 Data analysis was performed with a statistical software pack-
age (SigmaStat for Windows, Jandel Scientific, Erkrath, Germa-
ny). Nonparametric methods were used. Friedman repeated mea-
sures analysis of variance on ranks was applied within the groups. 
Time-dependent differences from the baseline were assessed by 
Dunn’s method. Differences between groups were analyzed with 
the Kruskal-Wallis and Dunn’s test. In the figures, median values 
and 75th and 25th percentiles are given. p values  ! 0.05 were con-
sidered significant. 
 Results 
 Macrohemodynamic Data 
 MAP decreased significantly during the reperfusion 
phase, and there were no differences in this parameter 
between groups 1 and 2. Similarly, a significant CI reduc-
tion was noted in the SBTX group during the reperfusion 
phase as compared to the baseline value or to the data of 
the sham-operated group. IPC before SBTX attenuated 
this change and the improvement in CI was significant at 
60 min and 240 min after reperfusion ( fig. 1 ). SMAF also 
decreased during the early phase of reperfusion as com-
pared with the preharvesting level. In the SBTX group the 
flow remained significantly lower throughout the whole 
period of reperfusion, while IPC stabilized SMAF on a 
significantly higher level ( fig. 2 ). 
 Microcirculatory Parameters 1 (IVM) 
 For technical reasons, IVM observations could not be 
performed before graft harvesting, and the baseline data 
for this parameter are therefore missing. The amount of 
leukocyte-endothelial cell interactions was significantly 
higher after SBTX than in the sham-operated group 3. 
Reperfusion was followed by steady, approximately 70% 
primary (rolling) and an increasing number of secondary 
(sticking) leukocyte-endothelial cell interactions in the 
postcapillary venules of the mesentery. IPC significantly 
reduced the percentages of rolling ( fig. 3 ) and the number 
of firmly adhered white blood cells too ( fig. 4 ).  
 Microcirculatory Parameters 2 (OPS) 
 SBTX and reperfusion induced a slight decrease in red 
blood cell velocity in the arterioles and venules of the vil-
li. After IPC, there was no significant difference in these 
parameters as compared with the corresponding values 
in the SBTX group (data not shown). 
 The villus capillary perfusion, quantified by function-
al capillary density, was significantly decreased during 
reperfusion in the SBTX group, while this parameter sta-
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 Fig. 3. Percentage of rolling leukocytes in the mesenteric postcap-
illary venules in the SBTX (black columns, n = 5), preconditioned 
SBTX (grey columns, n = 5) and sham-operated (white columns, 
n = 5) groups. The tops of the columns show the median values. 
The capped bars indicate the 25th and 75th percentiles, respec-
tively.  a  p  ! 0.05 between the sham-operated and SBTX or SBTX 
+ IPC groups,  b  p  ! 0.05 between SBTX and SBTX + IPC groups. 
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 Fig. 4. Number of adherent leukocytes in the mesenteric postcap-
illary venules in the SBTX (black columns, n = 5), preconditioned 
SBTX (grey columns, n = 5) and sham-operated (white columns, 
n = 5) groups. The tops of the columns show the median values. 
The capped bars indicate the 25th and 75th percentiles, respec-
tively.  a  p  ! 0.05 between the sham-operated and SBTX or SBTX 
+ IPC groups,  b  p  ! 0.05 between SBTX and SBTX + IPC groups. 
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bilized at close to the control level in the SBTX + IPC 
group ( fig. 5 ). 
 The epithelial thickness, a marker of mucosal epithe-
lial injury and epithelial integrity, decreased significant-
ly and progressively during reperfusion after SBTX, com-
pared to the baseline value or to the data of the sham-op-
erated group. The epithelial thickness in the IPC group 
was reduced at 60 min relative to baseline, but thereafter 
it was unchanged, suggesting less severe epithelial struc-
tural damage ( fig. 6 ). 
 Discussion 
 This study provides the first description of the mi-
crocirculatory consequences of IPC before SBTX. We 
observed the microcirculation directly with 2 different 
methods of intravital microscopy in a large animal (dog) 
model of SBTX. Cold graft perfusion, harvesting and 
vascular anastomoses were performed with autotrans-
plantation to mimic clinical conditions but to exclude 
possible immunological complications. Accordingly, 
these observations relate to clear I/R-related changes 
only. 
 Reperfusion of the intestinal graft was accompanied 
by significant macrocirculatory deterioration. The mes-
enteric blood flow decreased and the concomitantly fall-
ing CI remained lower during the 4 h of reperfusion. The 
CI is mainly determined by the heart rate and cardiac 
stroke volume. Since there was no considerable change in 
heart rate or cardiac preload (central venous pressure) or 
afterload (MAP), a depressed contractile function of the 
heart may have contributed to the reduced CI. This might 
suggest that myocardial depressant substrates were liber-
ated during reperfusion from the previously ischemic 
mesenteric vascular bed  [10] . The severe decrease in 
SMAF may, at least in part, be a consequence of the re-
duced CI, but the role of local mesenteric circulatory re-
actions cannot be ruled out. IPC stabilized both the 
SMAF and the CI near the control, preharvesting levels. 
The beneficial effect on the CI suggests that intestinal 
IPC may exert some distant effect on the myocardial 
function, probably by reducing the ischemic injury of the 
bowel, resulting in a lower extent of myocardial depres-
sant release  [10] . 
 In addition to systemic hemodynamic changes, sig-
nificant alterations were observed in the microcircula-
tory system of the mesenteric vascular bed. A consider-
able capillary perfusion failure evolved, in parallel with 
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 Fig. 5. Changes in functional capillary density in the SBTX (black 
columns, n = 5), preconditioned SBTX (grey columns, n = 5) and 
sham-operated (white columns, n = 5) groups. The tops of the 
columns show the median values. The capped bars indicate the 
25th and 75th percentiles, respectively.  a  p  ! 0.05 within groups 
versus baseline values,  b  p  ! 0.05 between the sham-operated and 
SBTX or SBTX + IPC groups,  c  p  ! 0.05 between SBTX and SBTX 
+ IPC groups. 
 Fig. 6. Epithelial thickness of the small intestinal villi in the SBTX 
(black columns, n = 5), preconditioned SBTX (grey columns, n = 
5) and sham-operated (white columns, n = 5) groups. The tops of 
the columns show the median values. The capped bars indicate 
the 25th and 75th percentiles, respectively.  a  p  ! 0.05 within 
groups versus baseline values,  b  p  ! 0.05 between the sham-oper-
ated and SBTX or SBTX + IPC groups,  c  p  ! 0.05 between SBTX 
and SBTX + IPC groups. 
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significant leukocyte-endothelial cell interactions. IPC, 
when applied before graft perfusion, improved the mi-
crocirculation and afforded protection from epithelial in-
jury. Our results are in accordance with those of Mallick 
et al.  [9] , who demonstrated an improved capillary perfu-
sion and a reduced amount of leukocyte-endothelial cell 
interactions following IPC in a rodent model of warm 
ischemia and reperfusion. We earlier observed similar 
changes in the same model and underlined the important 
role of endogenously liberated endothelin-1 in the patho-
genesis of these changes  [11] . Similar effects were ob-
served on the exogenous infusion of endothelin-1  [12] . It 
has been demonstrated that IPC protects the reperfused 
endothelium by reducing the endothelin-1-induced acti-
vation of NADPH oxidase and xanthine oxidase in the rat 
heart  [13] . On the other hand, the tissue microcirculation 
is regulated by different vasoactive mediators in both 
normal and pathologic conditions. With the suggestion 
of the important role of the vasoconstrictor and proadhe-
sive endothelin during reperfusion, the protective effect 
of IPC may be mediated by counterbalancing this effect. 
The consequence of I/R is that the endothelium is char-
acterized by decreased nitric-oxide (NO)-dependent re-
laxation. NO is one of the most potent endogenous vaso-
dilators and antiadhesive mediators  [14] and the role of 
NO has previously been demonstrated as a potential 
mechanism of IPC in the intestine  [15] . NO has been sus-
pected as an important factor in the adaptive processes 
following preconditioning both in the heart and in the 
intestine  [15–17] . Recent studies suggest that NO could 
have a bifunctional role, as a trigger  [18] and mediator in 
classic IPC  [19] . IPC may be a trigger for the constitu-
tively active intestinal endothelial and/or neuronal NO 
synthase, and NO is able to counterbalance the vasocon-
strictive effects of endothelin and other vasoactive me-
diators at the precapillary level. On the other hand, NO 
can also act as an antiadhesive mediator, limiting leuko-
cyte-endothelial cell interactions and leukocyte-mediat-
ed tissue injury. 
 The exact roles of NO and the different isoforms of NO 
synthase in IPC are not yet understood, however, it seems 
that the endothelial isoform is involved in early protection, 
while both endothelial and inducible NO synthase iso-
types play roles in delayed consequences of IPC  [20, 21] . 
 The development of leukocyte-endothelial cell inter-
actions requires the expression of adhesion molecules on 
the surface of leukocytes and endothelial cells. It has been 
reported that I/R induces a 7-fold increase in P-selectin 
expression in the rat jejunum, and IPC significantly de-
creases this expression. These data indicate that P-selec-
tin expression is a novel downstream effector target of the 
anti-inflammatory signaling pathway in IPC  [22] . 
 Probably all of the above-mentioned protective mech-
anisms may have contributed to the beneficial microcir-
culatory effects of IPC in our experiments, but we have to 
stress that this study focused on the early changes only. 
Nevertheless, the vascular endothelium of the reperfused 
tissue could be one of the most important target of IPC, 
and the prevention of endothelial dysfunction may result 
in reduced structural tissue injury. Although we did not 
perform histological investigations, the villi were direct-
ly observed with intravital microscopy, and the height 
and appearance of epithelial cell layer suggested that sig-
nificant tissue protection was induced by IPC. 
 Given the essential role of the endothelium and NO in 
the regulation of the vascular tone and the platelet and 
leukocyte functions, the protection of endothelial cells is 
an important therapeutic target. In this context, a num-
ber of studies have shown that both early and delayed 
preconditioning may prevent an endothelial dysfunction 
after I/R. This endothelial protection most probably re-
sults from the inhibitory effects of preconditioning on the 
expression of endothelial adhesion molecules, leading to 
reduced neutrophil-endothelial interactions. The mecha-
nisms of early endothelial preconditioning may involve 
mediators such as adenosine, bradykinin, NO and free 
radicals, together with the activation of protein kinase C 
and the opening of ATP-sensitive potassium channels. 
With regard to delayed preconditioning, recent studies 
have shown that both NO and free radicals are involved 
as triggers of this second window of endothelial protec-
tion. The complex interactions between these 2 radical 
species ultimately lead to a delayed increase in NO pro-
duction, which is most probably responsible for the de-
creased adhesion of neutrophils to endothelial cells  [23] . 
 Additionally to the microcirculatory failure developing 
during reperfusion, reactive oxygen free radicals generat-
ed during reperfusion of the hypoxic tissues or synthesized 
by activated leukocytes also play a pivotal role in the tissue 
injury  [24] and there is evidence that both early and late 
IPC reduces the reperfusion-linked oxidative stress in the 
small intestine  [25, 26] . It has been proposed that superox-
ide radicals play an important role in the signaling path-
way of IPC  [27] . Reactive hyperemia induced by short isch-
emic episodes provides the short-lived protection of early-
phase IPC through a xanthine-oxidase-dependent increase 
in superoxide production  [28] . A recent experimental 
study by our group demonstrated a reperfusion-induced 
significant increase in tissue xanthine oxidase activity and 
a marked elevation in superoxide production at the begin-
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ning of reperfusion. However, in the preconditioned ani-
mals, no significant change was observed at the beginning 
of reperfusion  [29, 30] . All these data suggest that IPC ex-
erts its beneficial effect by limiting free radical-mediated 
tissue injury during reperfusion. 
 In conclusion, our study has demonstrated for the first 
time the beneficial microcirculatory effects of IPC during 
the early phase of reperfusion following SBTX in a large 
animal model. The exact mechanisms of this consider-
able tissue-protective effect of IPC need further investi-
gation, especially as concerns the direction of potential 
pharmacological preconditioning, but the promising re-
sults suggest that IPC could be an optional method with 
which to reduce reperfusion injury in cases when bowel 
ischemia is predictable. 
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Background: Ischemicpreconditioning(IPC) canprovideadefenseagainst ischemiaereperfusion
(IR)-induced acute inflammation and barrier dysfunction inmany organs. Because nitric oxide
(NO) has been implicated as a trigger or mediator in the IPCmechanism and because neuronal
NO synthase (nNOS) is a dominant isoform of NOS in the gastrointestinal tract, our aimwas to
investigate the role of nNOS in IPC-induced protection after mesenteric IR.
Materials and methods: Intestinal IR was induced in sodium pentobarbitaleanesthetized
dogs by clamping the superior mesenteric artery for 60 min followed by 2 h of reperfu-
sion (IR group; n ¼ 7). In further groups, IPC was used (three cycles of 5-min ischemia/5-min
reperfusion periods) before IR in the presence or absence of selective inhibition of nNOS
with 7-nitroindazole (5 mg/kg, intravenously, in a bolus 15 min before IPC, n ¼ 6 each).
Changes in mesenteric vascular resistance, intramucosal pH (pHi), and small bowel
motility were monitored. Plasma nitrite/nitrate levels, intestinal NO synthase activity,
leukocyte accumulation, mast cell degranulation, and histologic injury were also
determined.
Results: Ischemia significantly decreased mesenteric vascular resistance and pHi, whereas
IR induced a temporary bowel hypermotility and acute inflammatory reaction. IPC facili-
tated pHi recovery, attenuated motility dysfunction, elevated NOS-dependent NO pro-
duction, and reduced leukocyte accumulation, mast cell degranulation, and mucosal
injury. Pretreatment with 7-nitroindazole halted the IPC-induced increase in NO avail-
ability, pHi recovery, and the anti-inflammatory and morphologic effects.
Conclusions: Our data demonstrate that NO generated by intestinal nNOS plays a pivotal
role in IPC-linked tissue protection by inhibiting an IR-related acute inflammatory
response.
ª 2019 Published by Elsevier Inc.Research, University of Szeged, Pulz u. 1, H-6724 Szeged, Hungary. Tel.: þ36-62 545-103; fax:
-szeged.hu (A. Szabo´).
shed by Elsevier Inc.
242 j o u rn a l o f s u r g i c a l r e s e a r c h  d e c em b e r 2 0 1 9 ( 2 4 4 ) 2 4 1e2 5 0Introduction guidelines on the use of experimental animals (NIH Publica-In past decades, the protective potential of ischemic pre-
conditioning (IPC) has been demonstrated in a number of or-
gans, including the gastrointestinal tract.1-3 The attenuating
effect of IPC against an ischemiaereperfusion (IR)-induced
inflammatory response in the intestine4 involves reduced
activation of transcription factor nuclear factor-kappa bind-
ing5 and cytoprotection through inhibition of apoptosis.6
Preservation of enteric nerve function and prevention of in-
testinal motility dysfunction represent another manifest
protective effect of IPC, at least in rats.7
Among many possible triggers and mediators, nitric oxide
(NO) seems to play a key initiating role in IPC-linked protec-
tion. This hypothesis is supported by the immediate increase
in tissue nitrite and nitrate (NOx) levels after IPC in the rat
intestine.2 It has also been shown that endogenous NO pro-
duction by NO synthases (NOSs) plays a regulatory role in
intestinal motility after reperfusion8 and the preservation of
mucosal barrier function on IR injury.9 Furthermore, NO-
releasing compounds or NO donors (e.g., SIN-1, sodium
nitroprusside, CAS 754, and FK409) exerted similar protection
against mucosal injury in rats,10 cats,11 and dogs12 as well.
Among the two calcium-dependent constitutive isoforms,
neuronal NO synthase (nNOS or type 1 NOS) is a dominant
isoenzyme in the small intestine of both rodents10 and large
animals.13 Nevertheless, the role of nNOS in intestinal IR
injuryeinduced acute inflammatory reactions is still debated.
A number of studies have demonstrated a proinflammatory
role for nNOS,14-16 but anti-inflammatory properties have also
been described.17 Furthermore, treatment with nNOS inhibi-
tor 7-nitroindazole (7-NI) in healthy rats for 4 d exhibited
higher intestinal myeloperoxidase (MPO), inducible NOS, and
nuclear factor-kappa binding activity with concomitant lower
IkBa expression.18 The paradoxical role of nNOS-mediated NO
signaling during inflammation may be due to the differences
in the severity and time course of model diseases (i.e., colitis,
sepsis, or cerebrovascular inflammation) and species differ-
ences (i.e., rodents versus larger animals) as well.
In the present study, we aimed to investigate the possible
role of nNOS in the local IPC-induced protection in the
gastrointestinal tract of a large animal model, where inner-
vation is similar to that of humans.19 To this end, 7-NI, a
specific nNOS inhibitor with a high neuronal uptake,20 was
administered before IPC in anesthetized dogs. Particular
emphasis was placed on intestinal motility function and in-
flammatory reactions in the early reperfusion phase when the
parallel involvement of NOS activation was also determined.Materials and methods
The experiments complied with the ARRIVE guidelines and
the project were approved by the National Scientific Ethics
Committee on Animal Experimentation (National Competent
Authority) in Hungary under license number V./148/2013. The
study was performed in compliance with EU Directive 2010/
63/EU on the protection of animals used for experimental and
other scientific purposes and the National Institutes of Healthtions No. 8023, revised 1978).
Surgical preparation
Outbred dogs of either sex with average body weight of
12.7  2 kg were obtained from the Animal House of the
University of Szeged (n ¼ 19). The animals were anesthetized
intravenously with sodium pentobarbital (30 mg/kg intrave-
nously), and polyethylene catheters were surgically inserted
into the femoral artery and vein to measure blood pressure
and administer fluids or drugs, respectively. All animals
received a continuous infusion of Ringer’s lactate at a rate of
10mL/kg/h during the experiments. Aftermedian laparotomy,
the root of the superiormesenteric artery (SMA) was dissected
free, and an ultrasonic flow probe (Transonic Systems Inc,
Ithaca, NY) was placed around the exposed SMA to measure
mesenteric blood flow. A branch of a tributary of the ileal vein
supplying the terminal part of the ileum was cannulated with
a 2-F polyethylene catheter to measure mesenteric venous
pressure so as to obtain blood samples (see later).
Experimental protocol
Ten male and nine female outbred dogs were randomly allo-
cated to IR (n ¼ 7; male ¼ 4 and female ¼ 3) and IPC (n ¼ 12;
male ¼ 6 and female ¼ 6) groups (Fig. 1). In the IR group,
mesenteric ischemia was elicited by occluding the SMA for
60 min with a miniclip, which was followed by 2 h of reper-
fusion. In the IPC group, animals were assigned into 7-
NIetreated or vehicle groups and were treated with the se-
lective nNOS inhibitor 7-NI (5 mg/kg; n ¼ 6; male ¼ 3 and
female¼ 3) or saline vehicle (n¼ 6; male¼ 3 and female¼ 3) in
an intravenous bolus 15 min before IPC. IPC was induced in
two groups by clamping the SMA using three cycles of 5-min
ischemia/5-min reperfusion periods starting 60 min before
IR. Stock solution of 7-NI (SigmaeAldrich Co, St. Louis, MO)
was dissolved in a mixture of 75% dimethyl sulfoxide/saline
and stored at 20C; the aliquots were diluted in 3 mL of 0.9%
saline before administration. In the IR group, animals were
treated with saline vehicle at a matching time point.
Blood samples were collected from the mesenteric vein for
later determination of plasma NOx levels at different time
points (Fig. 1). Tissue biopsies were also harvested from the
intestine for further biochemical/histologic (e.g., MPO, NOS
activity, and mast cell (MC) degranulation) analyses (at base-
line as well as at the 15th and 120th min of reperfusion).
Hemodynamic and blood gas measurements; calculation of
mucosal pH
The peripheral arterial and mesenteric venous pressures
(using Statham P23 Db transducers) were registered with a
computerized data acquisition system (Haemosys 1.17
Experimetria Ltd, Budapest, Hungary). Mesenteric vascular
resistance was calculated with a standard formula. A silastic
balloon catheter (TGS Tonomitor; Tonometrics Inc,Worcester,
MA) was introduced through a small enterotomy into the in-
testinal lumen. Arterial blood gases and intramucosal pCO2
Fig. 1 e Experimental protocol. In the first group, 60 min of ischemia was induced by occluding the SMA, which was
followed by 120 min of reperfusion (IR). In the two other groups, IR was preceded by IPC, which was elicited by inducing
three cycles of 5-min ischemia/5-min reperfusion periods in the presence and absence of a bolus injection of 7-NI (5 mg/kg)
15 min before IPC (IPCD IRD7-NI and IPCD IR groups, respectively). IR and IPCD IR groups were treated with a vehicle of 7-
NI (a mixture of 75% DMSO/saline) at corresponding time points. As indicated, blood samples from the mesenteric vein (BS)
and tissue biopsies from the affected bowel area (marked by an arrowhead) were also taken for later assessments of plasma
nitrate/nitrite levels and NOS and MPO activities, as well as to assess MC degranulation and mucosal injury.
v a r g a e t a l  nno s and i n t e s t i n a l p r e c on d i t i o n i n g 243weremeasured with a blood gas analyzer (AVL, Graz, Austria).
Intestinal pH (pHi) was calculated using the modified
HendersoneHasselbach formula with a correction factor for
30 min of equilibration.
Intestinal motility measurement
To monitor the small bowel motility, a modified strain gauge
transducer technique was applied,13 the transducers being
sutured to the circular muscle layer of a terminal ileal
segment. Motility index was calculated to estimate the
neurogenic integrity of the intestine.21
Plasma nitrate/nitrite level measurements
Plasma NOx concentrations were determined from samples
taken at baseline (t ¼ 30 min), before ischemia as well as the
15th, 60th, and 120th min of reperfusion by means of the
Griess reaction.13
Measurement of NOS enzyme activity
NOS activity was determined in intestinal tissue biopsies
based on the enzymatic conversion of 3[H]-L-arginine to 3[H]-
L-citrulline using the Lowrymethod; the Ca2 þ-dependent and
Ca2 þ-independent NOS activities were assessed in the pres-
ence and absence of Ca-calmodulin, respectively.13
Tissue MPO activity measurements
MPO, a marker of neutrophil granulocyte infiltration, was
measured from mucosal biopsies using a standard photo-
metric method.22Determination of MC degranulation
Ileal biopsies were placed into an ice-cold Carnoy’s fixative,
embedded in paraffin, sectioned (6 mm), and stained with
Alcian blue and Safranin O. Histologic analysis was performed
in coded sections by one investigator (S.V.) at 40 optical
magnification in a blinded fashion. MCs were differentiated
based on the location of granules, injury to the cell membrane,
and volume of the cytoplasm. Intact cells were characterized
by (1) intact membrane and (2) cytoplasmic granules, while
criteria for degranulated cells were specified by (1) cell mem-
brane injury, (2) reduced cytoplasmic volume and (3) loss of
cytoplasmic granules. The percentage of degranulation (MC
%) was calculated based on the number of intact MC (iMC)
and degranulated MC (dMC) mast cells: MC% ¼ dMC/
(dMC þ iMC).23
Determination of morphologic changes in the structure of
the small intestine
Analysis of morphologic injury to the same ileal biopsies was
performed on slides stained with hematoxylin-eosin in coded
slides in a blinded fashion. Measurements of the height of
different portions of the mucosa were conducted with a
computer-assisted image analysis system (IVM Pictron,
Budapest, Hungary). The extent of mucosal damage was
determined on the basis of (1) villus heightdtotal mucosal
height ratio (%) and (2) villus heightdcrypt height ratio (%);
thesewere determined for each villus of the current slide (at 3-
5 high power fields at 4magnification). Villus tip injury was
also assessed using a modified version of Chiu’s method for
each villus of the current slide (at 4-7 high power fields at 10
magnification).24
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Data analysis was performed using a statistical software
package (SigmaStat 13.0 version for Windows, Jandel Scienti-
fic, Erkrath, Germany) with nonparametric methods.
Normality was tested with the ShapiroeWilk test. Friedman’s
repeated measures analysis of variance on ranks was applied
within the groups. Time-dependent differences from the
baseline were assessed with Dunn’s method. Differences be-
tween groups were analyzed with the KruskaleWallis (one-
way analysis of variance on ranks) test, followed by Dunn’s
method for pairwise multiple comparison. Median values and
75th and 25th percentiles are illustrated in figures. Results were
considered significant at P < 0.05 value.Fig. 2 e Time course of changes in mesenteric vascular
resistance during baseline and during 60 min of SMA
occlusion followed by 120 min of reperfusion (IR group).
Further groups of animals were also subjected to IPC in the
presence and absence of 7-NI treatment (IPC D IRD7-NI
and IPC D IR groups, respectively). Here, values are
indicated as medians D 25th and 75th percentiles. Time-
dependent differences from the baseline were assessed
with Dunn’s method. Differences between groups were
analyzed with the KruskaleWallis (one-way analysis of
variance on ranks) test, followed by Dunn’s method for
pairwise multiple comparison.Results
Hemodynamic changes
Apart from an abrupt decrease during ischemia (because zero
flow and pressure during occlusion in the affected intestinal
area), no statistically significant differences between the
groups or in comparison with baseline values could be
detected in mesenteric vascular resistance (Fig. 2).
Changes in intramucosal pH
No difference in pHi values could be detected at baseline;
neither 7-NI nor IPC influenced this parameter (Fig. 3). In
response to 60 min of ischemia, however, a steep decrease in
pHi could be detected (P< 0.05) in all of the groups, which was
followed by a gradual recovery. Restoration in this parameter
appeared to be more rapid in both IPC groups as pHi values
were significantly higher than in the IR group during the 30th-
90thmin of reperfusion. At the end of reperfusion (reperfusion
120 min), pHi values were significantly higher only in the
IPC þ IR group than those in the test ischemia (IR) group.
Small bowel motility changes
Small bowel motility was not influenced by 7-NI alone or IPC
at baseline, but a transiently reducedmotility was observed in
the 7-NI-treated group immediately after the IPC procedure
(Fig. 4); this vanished in 30 min (just before the beginning of
ischemia). Ischemia alone did not induce any significant
changes in this parameter, but the early reperfusion phase
(30 min of reperfusion) was associated with an increased in-
testinal motility. This intestinal hypermotility was prevented
completely by IPC (to a similar extent in both the vehicle-
treated and 7-NIetreated groups), and at the 60th min of
reperfusion, even lowermotility values could be detected than
those seen at baseline. By the end of 2 h of reperfusion, the
motility index was normalized in all the groups.
Changes in plasma NOx levels
In the IR group, no significant changes in NOx values could be
detected at any phase of the experiments (Fig. 5). A temporary
increase was observed in the vehicle-treated IPC group inblood samples taken before the beginning of ischemia and in
both IPC groups at the beginning (at 15 min) of reperfusion.
This IPC-induced increase in NOx levels, however, was
missing in the 7-NIetreated IPC þ IR group; furthermore, a
marked increase in this parameter was seen at the last time
point (120th min) of reperfusion.
Changes in ileal NOS activities
Ca2þ-independent and Ca2þ-dependent NOS activities were
not significantly different between examined groups at base-
line (Fig. 6A and B). As for Ca2þ-independent NOS (iNOS) ac-
tivity, no statistically significant changes could be detected
throughout the entire experimental period in any of the
groups (Fig. 6B). In the IR group, Ca2þ-dependent NOS activity
showed no changes during any phase of the entire examina-
tion period either. In the vehicle-treated IPC group, however, a
marked increase in Ca2þ-dependent NOS activity was found at
the 15th min of reperfusion, but this increase was not present
in the 7-NIetreated group.
Changes in ileal MPO activity
The baseline MPO activities were similar in the different
groups (Fig. 7), but significant increases were seen at the 15th
and 120th min of reperfusion in the IR group and at the 15th
min of reperfusion in the 7-NI þ IPC þ IR groups. As compared
with the IR groups, a significant reduction in MPO activity was
evidenced in the IPC þ IR group at both examined time points
of reperfusion.
Fig. 3 e Time course of changes in intramucosal pH during
baseline and 60 min of SMA occlusion followed by 120 min
of reperfusion (IR group). Further groups of animals were
also subjected to IPC in the presence and absence of 7-NI
treatment (IPCD IRD7-NI and IPCD IR groups,
respectively). Here, values are indicated as mediansD 25th
and 75th percentiles. Time-dependent differences from the
baseline were assessed with Dunn’s method. Differences
between groups were analyzed with the KruskaleWallis
(one-way analysis of variance on ranks) test, followed by
Dunn’s method for pairwise multiple comparison. X
represents P<0.05 versusbaseline, and#P<0.05 versus IR.
Fig. 4 e Time course of changes in motility index during
baseline and during 60 min of SMA occlusion followed by
120 min of reperfusion (IR group). Further groups of
animals were also subjected to IPC in the presence and
absence of 7-NI treatment (IPC D IRD7-NI and IPC D IR
groups, respectively). Here, values are indicated as
medians D 25th and 75th percentiles. Time-dependent
differences from the baseline were assessed with Dunn’s
method. Differences between groups were analyzed with
the KruskaleWallis (one-way analysis of variance on
ranks) test, followed by Dunn’s method for pairwise
multiple comparison. X represents P< 0.05 versus
baseline, and #P< 0.05 versus IR.
Fig. 5 e Time course of changes in plasma NOx during
baseline andduring 120minof reperfusionafter a 60-minof
SMA occlusion (IR group). Further groups of animals were
also subjected to IPC in the presence and absence of 7-NI
treatment (IPCD IRD7-NI and IPCD IR groups,
respectively). Here, values are indicated as mediansD 25th
and 75th percentiles. Time-dependent differences from the
baseline were assessed with Dunn’s method. Differences
between groups were analyzed with the KruskaleWallis
(one-way analysis of variance on ranks) test, followed by
Dunn’s method for pairwise multiple comparison. X
represents P<0.05 versusbaseline, and#P<0.05 versus IR.
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Mast cell degranulation or mucosal injury was not present at
baseline in any of the groups (Fig. 8A-D, Fig. 9A and B, Fig. 10A).
Fifteen minutes of reperfusion after a 60-min SMA occlu-
sion caused a significant increase in mast cell degranulation
(Fig. 8A, Fig. 9C and D) and mucosal injury (as evidenced by
loss of enterocyte integrity and subepithelial changes; see
details in legend for Figs. 9 and 10) and a reduction in mucosal
thickness (Fig. 8C and D) in the IR and IPC þ IRþ7-NI groups.
These changes were exacerbated only moderately by the end
of the observation period (120 min of reperfusion). In the
IPC þ IR group, however, a significantly lower extent of both
mast cell degranulation and histologic injury were observed
than in the other groups (Figs. 8 and 10C).Discussion
These data confirm the results of previous studies2,5,6,25,26 on
the protective effect of IPC in the intestine with the involve-
ment of nNOS in the IPC-induced intestinal protection
demonstrated here for the first time. The alleviating effects of
IPCweremarked by amore rapid recovery of intramucosal pH,
restored IR-induced motility changes, and reduced local in-
flammatory reaction, including leukocyte accumulation and
mast cell degranulation. As a result, IPC preserved mucosal
integrity. Compared with rodents, pigs and dogs have similar
innervation of the circular muscle layer to that of humans,19
Fig. 6 e Changes in (A) constitutive NO synthase (Ca2D-dependent NOS) and (B) inducible NO synthase (Ca2D-independent
NOS) activities in the affected ileal segment during baseline and at 15 and 120 min of reperfusion (IR). Further groups of
animals were also subjected to IPC in the presence and absence of 7-NI treatment (IPC D IRD7-NI and IPC D IR groups,
respectively). Here, plots demonstrate the median (horizontal line in the box) and the 25th (lower whisker) and 75th (upper
whisker) percentiles. Time-dependent differences from the baseline were assessed with Dunn’s method. Differences
between groups were analyzed with the KruskaleWallis (one-way analysis of variance on ranks) test, followed by Dunn’s
method for a pairwise multiple comparison. X represents P< 0.05 versus baseline, and #P< 0.05 versus IR.
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in a complex and detailed fashion in this large animal model.
Reperfusion injury of the bowel affects different structural
elements of the bowel in a particular sequence. The early
reperfusion phase affects the integrity of the enterocyte lining
and the rest of the mucosa relatively early, followed by injury
of themuscle and neuronal structures.27 In our study, the IPC-
induced protection of the intestinal mucosal barrier (inFig. 7 e Changes in leukocyte accumulation (MPO activity)
in the affected ileal segment during baseline and at 15 and
120 min of reperfusion (IR). Further groups of animals were
also subjected to IPC in the presence and absence of 7-NI
treatment (IPC D IRD7-NI and IPC D IR groups,
respectively). Here, plots demonstrate the median
(horizontal line in the box) and the 25th (lower whisker)
and 75th (upper whisker) percentiles. Time-dependent
differences from the baseline were assessed with Dunn’s
method. Differences between groups were analyzed with
the KruskaleWallis (one-way analysis of variance on
ranks) test, followed by Dunn’s method for pairwise
multiple comparison. X represents P< 0.05 versus
baseline, and #P< 0.05 versus IR.particular the villus tips) developed as early as the 15thmin of
reperfusion, which persisted over the examined 120-min
reperfusion period. A similarly early (<120 min) protective
effect was also demonstrated by others in rats as well.5,6,25
The mechanisms of protection provided by IPC in the intes-
tine were strongly linked to oxidative stress4,5,28 but were also
attributed to NO-dependent mechanisms.2,29 A transient peak
in NO release was detected during the early postischemic
phase in the rat intestine,2 and this phenomenon was also
observed if IR was preceded by IPC.30 IR has been shown to
trigger nNOS expression at the early stages of reperfusion31
even as early as 5 min of reperfusion in vitro (in Guinea
pigs)32 or after 3 h of reperfusion in vivo in the rat jejunum.31
The effect of IPC on the expression and function of nNOS
was examined here for the first time (at least to our knowl-
edge). Specifically, an nNOS-dependent NO release can be
presumed in response to IPC as levels of NOmetabolites in the
venous effluent of the intestinewere effectively reducedwhen
the specific NOS inhibitor 7-NI was administered before IPC.
At the beginning (15th min) of reperfusion, the IPC-induced
increase in Ca-dependent NOS activity was also prevented
by 7-NI. We also saw a marked increase in NOx metabolites
occurring in the late phase of reperfusion (which is rather
unexpected); this can probably be explained by nonenzymatic
production of NO33 resulting from hypoxia via impairment of
the microcirculation in the postischemic bowel tissue.
Despite the previously observed debates,14-17 the contri-
bution of nNOS to IPC-induced postischemic reactions is
obviously positive in our study. Although the role of nNOS in
the mechanisms of IPC was not examined elsewhere in the
intestine, nNOS was also found to be protective in other or-
gans, such as in heart IPC (both in vitro and in vivo).34 This
protection in the heart involves reduced oxidative/nitrosative
stress, and the positive effects of IPC are lost after nonspecific
NOS inhibition and in nNOS knockout animals.35 Here, we
could not examine the effect of nNOS inhibition on IR-induced
changes (in adherence to the 3Rs approaches in animal
research), but others also demonstrated a predominantly
Fig. 8 e Changes in (A) MC degranulation, (B) mucosal histologic injury according to Chiu’s grade, and mucosal height ([C] as
expressed as villus/crypt height ratio and [D] villus/total mucosa height ratio) in samples taken from the affected ileal
segment during baseline and at 15 and 120 min of reperfusion (IR). Further groups of animals were also subjected to IPC in
the presence and absence of 7-NI treatment (IPCD IRD7-NI and IPCD IR groups, respectively). Here, plots demonstrate the
median (horizontal line in the box) and the 25th (lower whisker) and 75th (upper whisker) percentiles. Time-dependent
differences from the baseline were assessed with Dunn’s method. Differences between groups were analyzed with the
KruskaleWallis (one-way analysis of variance on ranks) test, followed by Dunn’s method for pairwise multiple comparison.
X represents P< 0.05 versus baseline, and #P< 0.05 versus IR.
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(with respect to bowel muscle contractility and poly-
morphonuclear leukocyte accumulation).36
It appears that bowel IR may cause blood supply-
dependent and nitrosative stressemediated neuronal injury
of the bowel, but this usually occurs after relatively long
ischemic challenges (also depending on the species) and
typically develops at later stages of reperfusion.7,8,37,38 Based
on examinations of bowel motility in the present study, we
found no major sign of neurogenic dysfunction of the bowel
within the observed reperfusion period; furthermore, we
noted a temporary postischemic enhancement in this regard
at an early stage of reperfusion. On the other hand, because 7-
NI was given before IPC, we had a chance to assess its direct
effects (independently of IR). Interestingly, this manifested in
an immediate, but temporary decrease in bowel motility.
Because nNOS immunoreactive myenteric neurons are
inhibitory motoneurons and descending interneurons, the
above effect of 7-NI on bowelmotility is surprising. It is known
that NO, synthesized at a peripheral level by nNOS, reduces
intestinal motility (as was demonstrated in the sheep, for
instance)39 via sustained smooth muscle hyperpolarization;
this causes inhibition of spontaneous motility.40 On the other
hand, nonspecific inhibition of nNOS reduced gastrointestinal
motility not only in our study but also elsewhere,8,41 and wefound a similar reducing effect of 7-NI on the colon motility in
a subacute bowel obstruction model as well.13 In nNOS
knockout animals, bowel motility (after 2 h of ischemia) did
not decrease at 3 h but did so at 48 h of reperfusion,36 whereas
reduced intestinal transit time (i.e., increased motility) was
observed under similar circumstances after nNOS inhibi-
tion.41 The effects of IPC- on IR-induced bowel motility
changes were only examined in the long term, showing that
IPC restores the reducedmotility caused by 30min of ischemia
followed 6 h of reperfusion in rats.42 In our study, IPC pre-
vented the IR-induced temporary increase in bowelmotility at
the early reperfusion phase, and 7-NI had no specific effect on
this reaction within the examined time frame.
Although postischemic mucosa/enterocyte injury is
believed to be linked mostly to intracellular free radical-
mediated processes, bowel IR also induces marked inflam-
matory reactions (e.g., polymorphonuclear leukocyte accu-
mulation and MC degranulation); these can also be inhibited
by IPC.43,44 We saw simultaneous early increases in both tis-
sue MPO and MC degranulation as early as 15 min after
ischemia, which were both ameliorated by IPC. Similar, rela-
tively early MPO changes were also demonstrated in rats
(examined 30-60 min after ischemia).41,43 The nNOS de-
pendency of the latter reaction was also proven as inhibition
of nNOS (or KO)36 reversed this protection. Interestingly, the
Fig. 9 e Representative micrographs showing mucosal MCs stained with Alcian blue and Safranin O at (A and C) lower (bar
denotes 200 mm) and (B and D) higher magnifications (bar denotes 50 mm). In Panel B, please note intact intracellular
granules, whereas Panel D shows a loss of intracellular granules and stained material dispersed diffusely and
extracellularly as signs of MC degranulation at the 120th min of reperfusion in the IR group. (Color version of figure is
available online.)
Fig. 10 e Representativemicrographs of the ileal mucosa stained with hematoxylin and eosin staining at (A) baseline and (B)
120 min of reperfusion in the IR group, (C) the IPCD IR group, and (D) the IPCD IRD7-NI group. Panels B and D demonstrate
massive epithelial lifting down the side of villi, denuded villi, increased cellularity of the lamina propria, hemorrhage, and
the end of the finger-like appearance of villous structures. Panel C displays the development of subepithelial Gruenhagen’s
space at the apex of the villus, capillary congestion, and extension of the subepithelial space with a lifting of the epithelial
layer from the lamina propria. The bar denotes 200 mm in all figures.
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dependent mediator release in the small bowel.44 In our
study, however, the IR-induced degranulation of MCs was not
increased, but rather greatly prevented by IPC, which was
reversed by 7-NI. It is therefore reasonable to assume that
altered MC degranulation is a manifestation of reduced in-
flammatory reactions caused by nNOS in this IPC model, and
this process may also be involved in mediating the structural
injury of the intestinal mucosa.
Apart from oxidative injury, the integrity of the enterocyte
lining is also highly dependent on adequate oxygen delivery.
Similar to others (although working with rats),45 our study
found evidence of relatively minor IR-induced macro-
hemodynamic changes, but microvascular perfusion (as esti-
mated indirectly by tonometry) underwent a marked and
lasting deterioration. The positive effects of IPC on IR-induced
deterioration of microvascular perfusion, tissue oxygenation,
and leukocyte-endothelial interaction within the microvas-
culature of the small intestine are in evidence here and in a
number of other studies.3,46,47 These reactions were also
explained with an IPC-induced reduction of intestinal oxida-
tive stress.28 It appears that our study is the first to show that
nNOS also plays a role in a more rapid microcirculatory re-
covery after bowel IPC. Because there was also remarkably
early evidence of an increase in MPO and the appearance of
morphologic injury in the reperfusion phase in our study, the
importance of leukocyte-mediated reactions in preserving
morphologic integrity (as another manifestation of nNOS-
dependent IPC effects) cannot be ruled out either.Conclusions
In the present study, the beneficial effects of intestinal IPC
were examined in a relatively detailed fashion (with respect to
pHi, motility dysfunction, leukocyte accumulation, mast cell
degranulation, and mucosal injury). Changes in some of the
examined parameters (in particular, in IPC-induced marked
increase in NO availability: e.g., NOx and constitutive NOS
activity, pHi, inflammatory, and morphologic changes) could
be influenced/reversed by pretreatment with the nNOS in-
hibitor 7-NI. Hence, our data strongly support the contribution
of intestinal nNOS enzyme in the protective effect of IPC
against the IR-related acute inflammatory response and
morphologic injury in the small intestine.
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